{
  "schema_version": "0.1.0",
  "case_id": "HR-ML034",
  "record_classification": {
    "synthetic": true,
    "banner": "SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD",
    "real_historical_name": true,
    "public_release_status": "draft"
  },
  "identity": {
    "person_id": "ML034",
    "display_name": "Lorraine Hansberry",
    "aliases": [
      "Lorraine Vivian Hansberry"
    ],
    "sex": "female",
    "era": "Mid-Late 20th Century",
    "nationality": "American",
    "historical_dates": {
      "birth": {
        "preferred": {
          "iso": "1930-05-19",
          "display": "May 19, 1930",
          "precision": "day",
          "calendar": "gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "1930",
              "display": "1930",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0006"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees with PBS and the reference encyclopedias."
          }
        ]
      },
      "death": {
        "preferred": {
          "iso": "1965-01-12",
          "display": "January 12, 1965",
          "precision": "day",
          "calendar": "gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "1965",
              "display": "1965",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0006"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees with PBS and the reference encyclopedias."
          }
        ]
      }
    },
    "synthetic_identity": {
      "mrn": "HR-ML034-SYN",
      "ssn": "000-34-7158",
      "date_of_birth": "1993-05-19",
      "name_policy": "real_historical_name",
      "fictional_facility": "St. Posthumous Health Center",
      "fictional_primary_clinician": "Odette Marchetti-Fields, MD",
      "fictional_consultant": {
        "name": "Samuel Adeyemi-Rourke, MD",
        "specialty": "Medical Oncology (gastrointestinal)"
      }
    }
  },
  "historical_timeline": [
    {
      "event_id": "EVT-0001",
      "date": {
        "iso": "1930-05-19",
        "display": "May 19, 1930",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Born in Chicago.",
      "claim_ids": [
        "CLM-0001"
      ]
    },
    {
      "event_id": "EVT-0002",
      "date": {
        "iso": "1940",
        "display": "1940",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "The Supreme Court decides Hansberry v. Lee, the family's challenge to a restrictive covenant.",
      "claim_ids": [
        "CLM-0002"
      ]
    },
    {
      "event_id": "EVT-0003",
      "date": {
        "iso": "1946",
        "display": "1946",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Her father dies suddenly in Mexico.",
      "claim_ids": [
        "CLM-0003"
      ]
    },
    {
      "event_id": "EVT-0004",
      "date": {
        "iso": "1953-06",
        "display": "June 1953",
        "precision": "month",
        "calendar": "gregorian"
      },
      "summary": "Marries Robert Nemiroff, three years after leaving Wisconsin for New York.",
      "claim_ids": [
        "CLM-0004"
      ]
    },
    {
      "event_id": "EVT-0005",
      "date": {
        "iso": "1959-03-11",
        "display": "March 11, 1959",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "A Raisin in the Sun opens on Broadway, the first play by a Black woman produced there.",
      "claim_ids": [
        "CLM-0005"
      ]
    },
    {
      "event_id": "EVT-0006",
      "date": {
        "iso": "1963-04",
        "display": "April 1963",
        "precision": "month",
        "calendar": "gregorian"
      },
      "summary": "Fainting spells and attacks of nausea begin, first thought to be a duodenal ulcer.",
      "claim_ids": [
        "CLM-0006"
      ]
    },
    {
      "event_id": "EVT-0007",
      "date": {
        "iso": "1963-06",
        "display": "By June 1963",
        "precision": "month",
        "calendar": "gregorian"
      },
      "summary": "After a collapse in pain and a ten-day admission in which cancer is diagnosed (she is told of anemia and bleeding ulcers), an unsuccessful operation in New York.",
      "claim_ids": [
        "CLM-0007",
        "CLM-0008",
        "CLM-0011"
      ]
    },
    {
      "event_id": "EVT-0008",
      "date": {
        "iso": "1963-08",
        "display": "August 1963",
        "precision": "month",
        "calendar": "gregorian"
      },
      "summary": "Surgery at the Lahey Clinic at the New England Baptist Hospital in Boston.",
      "claim_ids": [
        "CLM-0008"
      ]
    },
    {
      "event_id": "EVT-0009",
      "date": {
        "iso": "1964",
        "display": "1964",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Gives the To Be Young, Gifted and Black speech on an afternoon out of hospital; The Sign in Sidney Brustein's Window opens in October.",
      "claim_ids": [
        "CLM-0009"
      ]
    },
    {
      "event_id": "EVT-0010",
      "date": {
        "iso": "1965-01-12",
        "display": "January 12, 1965",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Dies of cancer at University Hospital in New York at 34.",
      "claim_ids": [
        "CLM-0010",
        "CLM-0011"
      ]
    }
  ],
  "claims": [
    {
      "claim_id": "CLM-0001",
      "statement": "Lorraine Vivian Hansberry was born in Chicago on May 19, 1930, the youngest of four children of Carl Augustus Hansberry, a successful real estate broker who founded one of the city's first Black banks, and Nannie Louise (Perry) Hansberry, a schoolteacher. Her grandfather had been born enslaved.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "May 19, 1930: born to Carl Augustus Hansberry, Sr. and Nannie Louise Hansberry in Chicago"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "Carl established one of the city's first black banks"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports",
          "locator": "youngest by seven years of four children; father a real estate broker, mother a schoolteacher; granddaughter of a freed enslaved person"
        },
        {
          "source_id": "SRC-0006",
          "relationship": "context",
          "locator": "roster birth date"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0002",
      "statement": "In 1937 her family moved into a house in the all-white Washington Park subdivision of Woodlawn in defiance of a racially restrictive covenant. The resulting case, Hansberry v. Lee, was decided in the family's favor by the U.S. Supreme Court in 1940.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Anchors the modern social history: a writer whose family fought housing segregation in court when she was a child.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "1937: moves his family to a home in the Woodlawn neighborhood's all-white Washington Park subdivision; 1940: Hansberry v. Lee"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "landmark U.S. Supreme Court ruling Hansberry v. Lee on 12 November 1940"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0003",
      "statement": "Her father died suddenly in Mexico in 1946 of a cerebral hemorrhage while planning to move the family there.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Family history entry; no other family medical history was found in the cited sources.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "1946: Carl dies suddenly in Mexico of a cerebral hemorrhage while planning to move his family there"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0004",
      "statement": "She enrolled at the University of Wisconsin in 1948, left in 1950 for New York, and wrote for the newspaper Freedom. In June 1953 she married Robert Nemiroff. Sources differ on when they divorced (1962 or 1964); they continued to work together.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Her working life as a writer anchors the modern social history; the marriage is recorded only as the sources state it.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "1948 University of Wisconsin; 1950 moves to New York City; June 1953 marries Robert; 1964 divorce obtained in Mexico"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "married Robert Nemiroff on 20 June 1953"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports",
          "locator": "divorced in 1962, though they continued to work together"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "married in 1953 (divorced 1964)"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0005",
      "statement": "A Raisin in the Sun opened at the Ethel Barrymore Theatre on Broadway on March 11, 1959, the first play by a Black woman to be produced on Broadway. It won the New York Drama Critics' Circle Award; she was the first Black playwright and, at 29, the youngest American to win it. In 1962 she moved to Croton-on-Hudson, New York.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Her documented career anchors the modern social history: a playwright at work on her next play.",
      "source_links": [
        {
          "source_id": "SRC-0005",
          "relationship": "supports",
          "locator": "opened at the Ethel Barrymore Theatre on March 11, 1959; the first play produced on Broadway by an African American woman; at 29, the youngest American to win a New York Critics' Circle award"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "the first African-American woman ever to have a play on Broadway"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "opened at the Ethel Barrymore Theatre on March 11, 1959"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "1962: moves to Croton-on-Hudson, New York"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0006",
      "statement": "One account dates the start of her illness to April 1963, when she began to suffer from fainting spells and attacks of nausea; tests pointed at first to what was suspected to be a duodenal ulcer.",
      "evidence_grade": "D",
      "certainty": "probable",
      "clinical_interpretation": "The anchor for the modern presenting problem (epigastric pain, nausea and near-fainting with iron deficiency anemia). The month comes from one reference work only.",
      "source_links": [
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "In April of 1963 ... began to suffer from fainting spells and attacks of nausea. Tests indicated what was at first suspected to be a duodenal ulcer"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0007",
      "statement": "In 1963 she had an attack, collapsed in pain and was in hospital for ten days, during which doctors diagnosed cancer; she was told she had anemia and bleeding ulcers.",
      "evidence_grade": "D",
      "certainty": "probable",
      "clinical_interpretation": "The documented diagnosis to which the modern diagnosis is linked. That she was not told the diagnosis is the historical contrast with the modern episode, in which it is explained to her plainly. The month is not given.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "Lorraine has an attack and collapses in pain. She is subsequently hospitalized for 10 days, during which time doctors diagnose her with cancer. She is told she has anemia and bleeding ulcers"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0008",
      "statement": "She had an unsuccessful operation in New York in June 1963 and surgery at the Lahey Clinic at the New England Baptist Hospital in Boston in August 1963; one account dates the operations to June 24 and August 2, and neither cured the cancer.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Documented surgery after the index date; the modern episode's operation is synthetic.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "Lorraine has an unsuccessful operation in New York. In August, Lorraine undergoes surgery at the Lahey Clinic at the New England Baptist Hospital in Boston"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "two operations, on June 24 and August 2; neither of the surgeries succeeded"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0009",
      "statement": "She kept writing and speaking through her illness. In May 1964, released from the hospital for the afternoon, she gave the speech that became known as To Be Young, Gifted and Black; in June she left her sickbed for a Town Hall debate; and in the fall she moved to a hotel near the rehearsals of The Sign in Sidney Brustein's Window, attending its opening night in October 1964.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Her documented wish to keep working anchors the modern plan built around her writing.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "released from the hospital for the afternoon, delivers what becomes known as the To Be Young, Gifted, and Black speech; leaves her sickbed; attends opening night"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "As her health rapidly deteriorated, Lorraine worked feverishly to prepare The Sign in Sidney Brustein's Window for rehearsal"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0010",
      "statement": "She died of cancer at University Hospital in New York on January 12, 1965, at 34; The Sign in Sidney Brustein's Window closed that night. Her funeral was held in Harlem on January 15.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "The documented death from cancer, to which the synthetic diagnosis is linked. History only, stated without detail.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "January 12, 1965: dies of cancer of the duodenum at the age of 34 at University Hospital. The Sign in Sidney Brustein's Window closes"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "died on January 12, 1965 (gives her age as 35); University Hospital"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "died of pancreatic cancer, aged 34; funeral in Harlem on January 15, 1965"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports",
          "locator": "Death date: January 12, 1965"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0011",
      "statement": "The primary site of her cancer is recorded differently: most reference works give pancreatic cancer; the PBS American Masters timeline gives cancer of the duodenum; and Women in World History describes colon cancer that had spread to the pancreas. One biography dates the diagnosis to 1964 rather than 1963.",
      "evidence_grade": "R",
      "certainty": "disputed",
      "clinical_interpretation": "Retrospective; the sources disagree and no pathology was found. The modern episode uses a pancreatic head adenocarcinoma invading the duodenum, which is compatible with the accounts of pancreatic and duodenal cancer; this is a teaching choice, not a resolution of the historical question.",
      "source_links": [
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "diagnosed with pancreatic cancer; died of pancreatic cancer"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports",
          "locator": "In 1964 ... Hansberry was diagnosed with pancreatic cancer"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "cancer of the duodenum"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "colon cancer that had spread to her pancreas"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    }
  ],
  "sources": [
    {
      "source_id": "SRC-0001",
      "title": "Lorraine Hansberry Biographical Timeline (American Masters: Lorraine Hansberry: Sighted Eyes/Feeling Heart)",
      "publisher": "PBS / WNET",
      "url": "https://www.pbs.org/wnet/americanmasters/lorraine-hansberry-sighted-eyes-feeling-heart-timeline/9879/",
      "source_type": "other",
      "published": "2018-01-11",
      "accessed": "2026-11-04",
      "rights_note": "Public broadcaster's documentary timeline; facts and short quotations used with citation."
    },
    {
      "source_id": "SRC-0002",
      "title": "Harris J. Hansberry, Lorraine Vivian (Scribner Encyclopedia of American Lives, Thematic Series: The 1960s)",
      "publisher": "Encyclopedia.com (Charles Scribner's Sons)",
      "url": "https://www.encyclopedia.com/humanities/encyclopedias-almanacs-transcripts-and-maps/hansberry-lorraine-vivian",
      "source_type": "other",
      "accessed": "2026-11-04",
      "rights_note": "Reference encyclopedia entry; facts used with citation."
    },
    {
      "source_id": "SRC-0003",
      "title": "Powers N. Hansberry, Lorraine (1930-1965) (Women in World History: A Biographical Encyclopedia)",
      "publisher": "Encyclopedia.com (Gale)",
      "url": "https://www.encyclopedia.com/women/dictionaries-thesauruses-pictures-and-press-releases/hansberry-lorraine-1930-1965",
      "source_type": "other",
      "accessed": "2026-11-04",
      "rights_note": "Reference encyclopedia entry; facts and short quotations used with citation; it gives her father's first name and her age at death differently from the other sources."
    },
    {
      "source_id": "SRC-0004",
      "title": "Lorraine Hansberry",
      "publisher": "Wikipedia",
      "url": "https://en.wikipedia.org/wiki/Lorraine_Hansberry",
      "source_type": "other",
      "accessed": "2026-11-04",
      "rights_note": "Tertiary source used for the dates of the two operations and of the Broadway opening, and as a pointer to its sources."
    },
    {
      "source_id": "SRC-0005",
      "title": "Lorraine Hansberry",
      "publisher": "Biography.com (A&E Television Networks)",
      "url": "https://www.biography.com/writer/lorraine-hansberry",
      "source_type": "other",
      "published": "2023-08-16",
      "accessed": "2026-11-04",
      "rights_note": "Popular biography; used for her childhood, the Broadway firsts, and as the source that dates the diagnosis to 1964."
    },
    {
      "source_id": "SRC-0006",
      "title": "HISTMED Master Roster v3",
      "publisher": "The Human Record project",
      "url": "https://humanrecord.example.org/internal/HISTMED_Master_Roster_v3.xlsx",
      "source_type": "other",
      "published": "2026-11-04",
      "accessed": "2026-11-04",
      "rights_note": "Internal source locator; inherited claims remain provisional until corroborated."
    }
  ],
  "synthetic_episode": {
    "calendar_frame": "modern_shifted",
    "index_date": "2026-04-20",
    "index_age": 32,
    "date_shift_policy": "HR-DATE-SHIFT-1",
    "teaching_objective": "Recognize pancreatic cancer in a young Black woman whose epigastric and back pain, weight loss, new diabetes and iron deficiency anemia could be put down to an ulcer or to stress, and care for it on the NCCN pancreatic adenocarcinoma guideline and the ASCO guidelines on potentially curable pancreatic cancer, palliative care and supportive care: pancreas-protocol CT and endoscopy at once; tissue by endoscopic ultrasound and biliary drainage before CA 19-9 is read; resectability staging and a multidisciplinary tumor board; germline genetic testing for every patient with pancreatic cancer and molecular profiling of the tumor; modified FOLFIRINOX before surgery for borderline resectable disease, with dose and support matched to her fitness; pancreaticoduodenectomy and chemotherapy after it; palliative care from the day of diagnosis; pain, nutrition and pancreatic enzyme replacement; diabetes caused by the pancreatic disease; venous thromboembolism risk; fertility and contraception; plain disclosure of the diagnosis and its prognosis; and a plan built around her wish to keep writing. Black Americans with pancreatic cancer are less often offered surgery and have worse survival, so each step is checked for delay.",
    "visit_schedule": [
      {
        "encounter_id": "ENC-001",
        "date": "2026-04-20",
        "purpose": "Two months of epigastric and back pain, weight loss, black stools and near-fainting in a woman of 32: examination, blood tests, and urgent upper endoscopy and pancreas-protocol CT"
      },
      {
        "encounter_id": "ENC-002",
        "date": "2026-05-04",
        "purpose": "Diagnosis of pancreatic adenocarcinoma: tumor board plan, medical oncology consultation, genetic counseling, early palliative care, and planning of chemotherapy before surgery"
      },
      {
        "encounter_id": "ENC-003",
        "date": "2026-06-29",
        "purpose": "Day 1 of cycle 4 of modified FOLFIRINOX: toxicity review, genetic and tumor profiling results, thromboprophylaxis, nutrition and mood"
      },
      {
        "encounter_id": "ENC-006",
        "date": "2026-07-16",
        "purpose": "Same-day sick visit for diarrhea during chemotherapy"
      },
      {
        "encounter_id": "ENC-004",
        "date": "2026-08-10",
        "purpose": "After six cycles: restaging CT and CA 19-9, decision for surgery, and preparation for pancreaticoduodenectomy"
      },
      {
        "encounter_id": "ENC-005",
        "date": "2026-10-05",
        "purpose": "Six weeks after pancreaticoduodenectomy: pathology, diabetes and enzyme replacement after surgery, and the plan for chemotherapy after surgery"
      },
      {
        "encounter_id": "ENC-007",
        "date": "2026-10-21",
        "purpose": "Periodic adult preventive visit during chemotherapy after surgery"
      }
    ]
  },
  "clinical": {
    "problems": [
      {
        "id": "PRB-001",
        "display": "Epigastric pain for about two months, boring through to the back and worse after meals and lying flat, with nausea, early fullness, a loss of 5 kg (8 percent of her weight), and pale, loose stools: an upper abdominal cause such as a bleeding ulcer or a pancreatic or duodenal tumor must be found. Upper endoscopy and pancreas-protocol CT booked this week",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "R10.13",
            "display": "Epigastric pain",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic presenting problem anchored to the documented collapse in pain and the account of a suspected duodenal ulcer. Superseded by the diagnosis at the second visit.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "abatement_date": "2026-05-04"
      },
      {
        "id": "PRB-002",
        "display": "Iron deficiency anemia from chronic upper gastrointestinal blood loss: black stools on and off for three weeks, two near-fainting spells, hemoglobin 9.1 g/dL, MCV 74 fL, ferritin 6 ng/mL",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "D50.0",
            "display": "Iron deficiency anemia secondary to blood loss (chronic)",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic finding anchored to the documented account that she was told she had anemia and bleeding ulcers.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active"
      },
      {
        "id": "PRB-003",
        "display": "New hyperglycemia: A1c 6.6% and random glucose 132 mg/dL in a lean woman of 32 who is losing weight; new diabetes with weight loss can be the first sign of a pancreatic cancer, so it is to be confirmed and explained, not labeled type 2",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "R73.09",
            "display": "Other abnormal glucose",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic finding; superseded when diabetes due to the pancreatic cancer was recorded at the second visit.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "abatement_date": "2026-05-04"
      },
      {
        "id": "PRB-004",
        "display": "Adenocarcinoma of the head of the pancreas, 3.1 cm, invading the duodenum, borderline resectable (tumor contact of more than half the circumference of the superior mesenteric vein, no arterial contact), no distant spread, CA 19-9 486 U/mL after biliary drainage; on EUS-guided biopsy; synthetic modern detail linked to her documented cancer, whose primary site the sources record differently",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "C25.0",
            "display": "Malignant neoplasm of head of pancreas",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010",
            "CLM-0011"
          ],
          "synthetic_reason": "Synthetic histology, site, stage and course; the sources say she died of cancer and differ on whether it was pancreatic, duodenal, or colonic with spread to the pancreas (R). See sources.md.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "both_with_link",
        "recorded_date": "2026-05-04"
      },
      {
        "id": "PRB-005",
        "display": "Diabetes due to the pancreatic cancer (pancreatogenic, type 3c): A1c 6.6% at intake and fasting glucose 141 mg/dL",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "E08.9",
            "display": "Diabetes mellitus due to underlying condition without complications",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic consequence of the synthetic tumor.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-05-04"
      },
      {
        "id": "PRB-006",
        "display": "Exocrine pancreatic insufficiency from obstruction of the pancreatic duct: pale, floating, loose stools after fatty meals and weight loss",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "K86.81",
            "display": "Exocrine pancreatic insufficiency",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic consequence of the synthetic tumor; diagnosed clinically, as guidance allows in pancreatic cancer.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-05-04"
      },
      {
        "id": "PRB-007",
        "display": "Cancer-related pain in the upper abdomen and back, 6 out of 10, with sleep broken by it",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "G89.3",
            "display": "Neoplasm related pain (acute) (chronic)",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic symptom of the synthetic tumor.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-05-04"
      },
      {
        "id": "PRB-008",
        "display": "Obstruction of the distal common bile duct by the tumor, relieved by a covered metal stent placed at ERCP",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "K83.1",
            "display": "Obstruction of bile duct",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic consequence of the synthetic tumor.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-05-04",
        "abatement_date": "2026-10-05"
      },
      {
        "id": "PRB-010",
        "display": "Chemotherapy-induced diarrhea from irinotecan, grade 2 (five to six watery stools a day above her usual), starting on day 3 of cycle 5, with low potassium and magnesium and mild dehydration; no fever, blood or neutropenia; resolved",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "K52.1",
            "display": "Toxic gastroenteritis and colitis",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic treatment effect; not a historical claim.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-07-16",
        "abatement_date": "2026-08-10"
      },
      {
        "id": "PRB-009",
        "display": "Oxaliplatin peripheral neuropathy, grade 1: tingling in the fingers and toes in the cold, lasting a few days after each cycle, with mild tingling at the fingertips between cycles; no effect on writing or buttons",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "G62.0",
            "display": "Drug-induced polyneuropathy",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic common effect of oxaliplatin.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:30:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-06-29"
      },
      {
        "id": "PRB-011",
        "display": "After pylorus-preserving pancreaticoduodenectomy with superior mesenteric vein resection: loss of the head of the pancreas, with more marked exocrine insufficiency and insulin-requiring diabetes",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "Z90.411",
            "display": "Acquired partial absence of pancreas",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic consequence of the synthetic operation.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:30:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-10-05"
      }
    ],
    "medications": [
      {
        "id": "MED-001",
        "display": "Pantoprazole 40 mg delayed-release oral tablet, one tablet by mouth once daily before breakfast",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "314200",
            "display": "pantoprazole 40 MG Delayed Release Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet daily before breakfast"
        },
        "start_date": "2026-04-20",
        "indication_problem_ids": [
          "PRB-001",
          "PRB-002"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic acid suppression for suspected upper gastrointestinal bleeding, started before the endoscopy.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "MED-002",
        "display": "Ferric carboxymaltose 50 mg/mL injection, 750 mg intravenously, two doses one week apart",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "1435169",
            "display": "15 ML ferric carboxymaltose 50 MG/ML Injection",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 750,
          "unit": "mg"
        },
        "route": "intravenous",
        "frequency": {
          "period": 7,
          "period_unit": "d",
          "text": "750 mg intravenously; two doses one week apart"
        },
        "start_date": "2026-04-24",
        "end_date": "2026-05-01",
        "indication_problem_ids": [
          "PRB-002"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic intravenous iron for iron deficiency anemia from blood loss; oral iron would be slow and poorly tolerated with the upper abdominal symptoms.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "MED-003",
        "display": "Oxycodone 5 mg oral tablet, one tablet by mouth every 4 hours as needed for pain",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "1049621",
            "display": "oxycodone hydrochloride 5 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 4,
          "period_unit": "h",
          "text": "One tablet every 4 hours as needed"
        },
        "start_date": "2026-05-04",
        "indication_problem_ids": [
          "PRB-007"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic low-dose opioid for cancer pain, started at diagnosis with a bowel regimen.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:30:00-05:00"
        }
      },
      {
        "id": "MED-004",
        "display": "Senna 8.6 mg oral tablet, two tablets by mouth at night while taking oxycodone",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "312935",
            "display": "sennosides, USP 8.6 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 2,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "Two tablets at night"
        },
        "start_date": "2026-05-04",
        "indication_problem_ids": [
          "PRB-007"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic bowel regimen with an opioid.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:30:00-05:00"
        }
      },
      {
        "id": "MED-005",
        "display": "Pancrelipase delayed-release capsule (lipase 36,000 units), two capsules with each meal and one with each snack",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "1373325",
            "display": "amylase 180000 UNT / lipase 36000 UNT / protease 114000 UNT Delayed Release Oral Capsule",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 2,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "Two capsules with each meal, one with each snack"
        },
        "start_date": "2026-05-04",
        "end_date": "2026-10-05",
        "indication_problem_ids": [
          "PRB-006"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic pancreatic enzyme replacement for exocrine insufficiency from duct obstruction (about 72,000 lipase units with meals).",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:30:00-05:00"
        }
      },
      {
        "id": "MED-006",
        "display": "Oxaliplatin 5 mg/mL injection, 135 mg (85 mg/m2) intravenously over 2 hours on day 1 of each 14-day cycle, for six cycles",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "1736776",
            "display": "10 ML oxaliplatin 5 MG/ML Injection",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 135,
          "unit": "mg"
        },
        "route": "intravenous",
        "frequency": {
          "period": 14,
          "period_unit": "d",
          "text": "Day 1 every 14 days for six cycles"
        },
        "start_date": "2026-05-18",
        "end_date": "2026-07-27",
        "indication_problem_ids": [
          "PRB-004"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic modified FOLFIRINOX before surgery; body surface area 1.58 m2.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:30:00-05:00"
        }
      },
      {
        "id": "MED-007",
        "display": "Irinotecan 20 mg/mL injection, 238 mg (150 mg/m2) intravenously over 90 minutes on day 1 of each 14-day cycle, cycles 1 to 5",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "1726324",
            "display": "5 ML irinotecan hydrochloride 20 MG/ML Injection",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 238,
          "unit": "mg"
        },
        "route": "intravenous",
        "frequency": {
          "period": 14,
          "period_unit": "d",
          "text": "Day 1 every 14 days, cycles 1 to 5"
        },
        "start_date": "2026-05-18",
        "end_date": "2026-07-13",
        "indication_problem_ids": [
          "PRB-004"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic modified FOLFIRINOX before surgery, with atropine available in the infusion center for early cholinergic symptoms.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:30:00-05:00"
        }
      },
      {
        "id": "MED-008",
        "display": "Irinotecan 20 mg/mL injection, 190 mg (120 mg/m2, one dose level lower) intravenously on day 1 of cycle 6",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "1726324",
            "display": "5 ML irinotecan hydrochloride 20 MG/ML Injection",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 190,
          "unit": "mg"
        },
        "route": "intravenous",
        "frequency": {
          "period": 14,
          "period_unit": "d",
          "text": "Day 1 of cycle 6"
        },
        "start_date": "2026-07-27",
        "end_date": "2026-07-27",
        "indication_problem_ids": [
          "PRB-004"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic dose reduction after grade 2 diarrhea in cycle 5.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:30:00-05:00"
        }
      },
      {
        "id": "MED-009",
        "display": "Leucovorin 10 mg/mL injection, 634 mg (400 mg/m2) intravenously over 2 hours on day 1 of each 14-day cycle, for six cycles",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "2099993",
            "display": "10 ML leucovorin 10 MG/ML Injection",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 634,
          "unit": "mg"
        },
        "route": "intravenous",
        "frequency": {
          "period": 14,
          "period_unit": "d",
          "text": "Day 1 every 14 days for six cycles"
        },
        "start_date": "2026-05-18",
        "end_date": "2026-07-27",
        "indication_problem_ids": [
          "PRB-004"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic modified FOLFIRINOX before surgery.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:30:00-05:00"
        }
      },
      {
        "id": "MED-010",
        "display": "Fluorouracil 50 mg/mL injection, 3800 mg (2400 mg/m2) by continuous infusion over 46 hours through the port from day 1 of each 14-day cycle, for six cycles, with no bolus",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "239177",
            "display": "fluorouracil 50 MG/ML Injectable Solution",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 3800,
          "unit": "mg"
        },
        "route": "intravenous",
        "frequency": {
          "period": 14,
          "period_unit": "d",
          "text": "46-hour infusion from day 1 every 14 days for six cycles"
        },
        "start_date": "2026-05-18",
        "end_date": "2026-07-29",
        "indication_problem_ids": [
          "PRB-004"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic modified FOLFIRINOX before surgery.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:30:00-05:00"
        }
      },
      {
        "id": "MED-011",
        "display": "Pegfilgrastim 6 mg/0.6 mL prefilled syringe, 6 mg under the skin on day 3 of each cycle, after the pump is disconnected",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "727539",
            "display": "0.6 ML pegfilgrastim 10 MG/ML Prefilled Syringe",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 6,
          "unit": "mg"
        },
        "route": "subcutaneous",
        "frequency": {
          "period": 14,
          "period_unit": "d",
          "text": "6 mg on day 3 of each cycle"
        },
        "start_date": "2026-05-20",
        "end_date": "2026-07-29",
        "indication_problem_ids": [
          "PRB-004"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic primary prophylaxis against febrile neutropenia with modified FOLFIRINOX.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:30:00-05:00"
        }
      },
      {
        "id": "MED-012",
        "display": "Ondansetron 8 mg oral tablet, one tablet by mouth every 8 hours as needed for nausea",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "312086",
            "display": "ondansetron 8 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 8,
          "period_unit": "h",
          "text": "One tablet every 8 hours as needed"
        },
        "start_date": "2026-05-18",
        "indication_problem_ids": [
          "PRB-004"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic rescue antiemetic; fosaprepitant, palonosetron and one dose of dexamethasone are given in the infusion center on day 1.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:30:00-05:00"
        }
      },
      {
        "id": "MED-013",
        "display": "Olanzapine 5 mg oral tablet, one tablet by mouth at night on days 1 to 4 of each cycle",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "312078",
            "display": "olanzapine 5 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet at night on days 1 to 4"
        },
        "start_date": "2026-05-18",
        "indication_problem_ids": [
          "PRB-004"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic olanzapine-based antiemetic prevention that spares dexamethasone after day 1 because of her diabetes.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:30:00-05:00"
        }
      },
      {
        "id": "MED-014",
        "display": "Loperamide 2 mg oral capsule, two capsules at the first loose stool, then one after each loose stool, no more than eight a day unless directed",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "978006",
            "display": "loperamide hydrochloride 2 MG Oral Capsule",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 2,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "4 mg at onset, then 2 mg after each loose stool"
        },
        "start_date": "2026-05-18",
        "indication_problem_ids": [
          "PRB-004"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic plan for irinotecan late diarrhea, taught before cycle 1.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:30:00-05:00"
        }
      },
      {
        "id": "MED-015",
        "display": "Apixaban 2.5 mg oral tablet, one tablet by mouth twice daily during chemotherapy, stopped three days before surgery",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "1364435",
            "display": "apixaban 2.5 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 12,
          "period_unit": "h",
          "text": "One tablet twice daily"
        },
        "start_date": "2026-06-29",
        "end_date": "2026-08-21",
        "indication_problem_ids": [
          "PRB-004"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic primary thromboprophylaxis for a Khorana score of 3, started once the duodenal bleeding had settled.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:30:00-05:00"
        }
      },
      {
        "id": "MED-016",
        "display": "Potassium chloride 20 mEq extended-release tablet, two tablets by mouth today, then one tablet daily for three days",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "198116",
            "display": "potassium chloride 20 MEQ Extended Release Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "40 mEq today, then 20 mEq daily for three days"
        },
        "start_date": "2026-07-16",
        "end_date": "2026-07-19",
        "indication_problem_ids": [
          "PRB-010"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic potassium replacement after diarrhea.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:30:00-05:00"
        }
      },
      {
        "id": "MED-017",
        "display": "Enoxaparin 40 mg/0.4 mL prefilled syringe, 40 mg under the skin once daily for 28 days after surgery",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "854235",
            "display": "0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 40,
          "unit": "mg"
        },
        "route": "subcutaneous",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "40 mg once daily for 28 days"
        },
        "start_date": "2026-08-24",
        "end_date": "2026-09-21",
        "indication_problem_ids": [
          "PRB-004"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic extended thromboprophylaxis after major abdominal cancer surgery.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:30:00-05:00"
        }
      },
      {
        "id": "MED-018",
        "display": "Insulin glargine 100 units/mL pen, 8 units under the skin at night",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "847230",
            "display": "3 ML insulin glargine 100 UNT/ML Pen Injector",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 8,
          "unit": "[iU]"
        },
        "route": "subcutaneous",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "8 units at night"
        },
        "start_date": "2026-08-28",
        "end_date": "2026-10-05",
        "indication_problem_ids": [
          "PRB-005"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic basal insulin started after pancreaticoduodenectomy, when glucose rose.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:30:00-05:00"
        }
      },
      {
        "id": "MED-019",
        "display": "Insulin glargine 100 units/mL pen, 10 units under the skin at night",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "847230",
            "display": "3 ML insulin glargine 100 UNT/ML Pen Injector",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 10,
          "unit": "[iU]"
        },
        "route": "subcutaneous",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "10 units at night"
        },
        "start_date": "2026-10-05",
        "indication_problem_ids": [
          "PRB-005"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic dose increase for fasting readings of 140 to 170 mg/dL.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:30:00-05:00"
        }
      },
      {
        "id": "MED-020",
        "display": "Pancrelipase delayed-release capsule (lipase 36,000 units), three capsules with each meal and two with each snack",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "1373325",
            "display": "amylase 180000 UNT / lipase 36000 UNT / protease 114000 UNT Delayed Release Oral Capsule",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 3,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "Three capsules with each meal, two with each snack"
        },
        "start_date": "2026-10-05",
        "indication_problem_ids": [
          "PRB-006",
          "PRB-011"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic higher enzyme dose after resection of the head of the pancreas.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:30:00-05:00"
        }
      },
      {
        "id": "MED-021",
        "display": "Irinotecan 20 mg/mL injection, 184 mg (120 mg/m2) intravenously on day 1 of each 14-day cycle, for six cycles after surgery",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "1726324",
            "display": "5 ML irinotecan hydrochloride 20 MG/ML Injection",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 184,
          "unit": "mg"
        },
        "route": "intravenous",
        "frequency": {
          "period": 14,
          "period_unit": "d",
          "text": "Day 1 every 14 days for six cycles"
        },
        "start_date": "2026-10-12",
        "indication_problem_ids": [
          "PRB-004"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic chemotherapy after surgery without oxaliplatin; body surface area 1.53 m2; the reduced irinotecan dose is kept.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:30:00-05:00"
        }
      },
      {
        "id": "MED-022",
        "display": "Leucovorin 10 mg/mL injection, 612 mg (400 mg/m2) intravenously on day 1 of each 14-day cycle, for six cycles after surgery",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "2099993",
            "display": "10 ML leucovorin 10 MG/ML Injection",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 612,
          "unit": "mg"
        },
        "route": "intravenous",
        "frequency": {
          "period": 14,
          "period_unit": "d",
          "text": "Day 1 every 14 days for six cycles"
        },
        "start_date": "2026-10-12",
        "indication_problem_ids": [
          "PRB-004"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic chemotherapy after surgery.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:30:00-05:00"
        }
      },
      {
        "id": "MED-023",
        "display": "Fluorouracil 50 mg/mL injection, 3670 mg (2400 mg/m2) by continuous infusion over 46 hours from day 1 of each 14-day cycle, for six cycles after surgery",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "239177",
            "display": "fluorouracil 50 MG/ML Injectable Solution",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 3670,
          "unit": "mg"
        },
        "route": "intravenous",
        "frequency": {
          "period": 14,
          "period_unit": "d",
          "text": "46-hour infusion from day 1 every 14 days for six cycles"
        },
        "start_date": "2026-10-12",
        "indication_problem_ids": [
          "PRB-004"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic chemotherapy after surgery.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:30:00-05:00"
        }
      },
      {
        "id": "MED-024",
        "display": "Pegfilgrastim 6 mg/0.6 mL prefilled syringe, 6 mg under the skin on day 3 of each cycle after surgery",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "727539",
            "display": "0.6 ML pegfilgrastim 10 MG/ML Prefilled Syringe",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 6,
          "unit": "mg"
        },
        "route": "subcutaneous",
        "frequency": {
          "period": 14,
          "period_unit": "d",
          "text": "6 mg on day 3 of each cycle"
        },
        "start_date": "2026-10-14",
        "indication_problem_ids": [
          "PRB-004"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic growth factor support continued with chemotherapy after surgery.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:30:00-05:00"
        }
      },
      {
        "id": "MED-025",
        "display": "Apixaban 2.5 mg oral tablet, one tablet by mouth twice daily during chemotherapy after surgery",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "1364435",
            "display": "apixaban 2.5 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 12,
          "period_unit": "h",
          "text": "One tablet twice daily"
        },
        "start_date": "2026-10-12",
        "indication_problem_ids": [
          "PRB-004"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic thromboprophylaxis resumed with chemotherapy after surgery.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:30:00-05:00"
        }
      }
    ],
    "allergies": [
      {
        "id": "ALG-001",
        "display": "No known allergy",
        "status": "active",
        "assertion": "no_known_allergy",
        "substance": {
          "system": "http://snomed.info/sct",
          "code": "716186003",
          "display": "No known allergy"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic allergy assertion for EHR completeness; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      }
    ],
    "observations": [
      {
        "id": "OBS-HGB-V1",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-20",
        "value": 9.1,
        "unit": "g/dL",
        "reference_range": {
          "low": 12.0,
          "high": 15.5
        },
        "interpretation": "L",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic blood count at presentation: microcytic anemia after weeks of black stools. No result from her life is known; synthetic value.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-MCV-V1",
        "display": "MCV [Entitic mean volume] in Red Blood Cells by Automated count",
        "label": "MCV",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-20",
        "value": 74,
        "unit": "fL",
        "reference_range": {
          "low": 80,
          "high": 100
        },
        "interpretation": "L",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "787-2",
            "display": "MCV [Entitic mean volume] in Red Blood Cells by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic blood count at presentation: microcytic anemia after weeks of black stools. No result from her life is known; synthetic value.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-WBC-V1",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White cell count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-20",
        "value": 7.4,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic blood count at presentation: microcytic anemia after weeks of black stools. No result from her life is known; synthetic value.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V1",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-20",
        "value": 388,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic blood count at presentation: microcytic anemia after weeks of black stools. No result from her life is known; synthetic value.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-FERR-V1",
        "display": "Ferritin [Mass/volume] in Serum or Plasma",
        "label": "Ferritin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-20",
        "value": 6,
        "unit": "ng/mL",
        "reference_range": {
          "low": 15,
          "high": 150
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2276-4",
            "display": "Ferritin [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic ferritin: iron deficiency from chronic blood loss.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-NA-V1",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-20",
        "value": 138,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic chemistry at presentation: a cholestatic pattern and a raised random glucose.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-K-V1",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-20",
        "value": 4.0,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic chemistry at presentation: a cholestatic pattern and a raised random glucose.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V1",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-20",
        "value": 0.7,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.59,
          "high": 1.04
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic chemistry at presentation: a cholestatic pattern and a raised random glucose.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V1",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-20",
        "value": 118,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic chemistry at presentation: a cholestatic pattern and a raised random glucose.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V1",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-20",
        "value": 132,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "H",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic chemistry at presentation: a cholestatic pattern and a raised random glucose.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V1",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-20",
        "value": 48,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 35
        },
        "interpretation": "H",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic chemistry at presentation: a cholestatic pattern and a raised random glucose.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V1",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-20",
        "value": 41,
        "unit": "U/L",
        "reference_range": {
          "low": 8,
          "high": 35
        },
        "interpretation": "H",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic chemistry at presentation: a cholestatic pattern and a raised random glucose.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-ALP-V1",
        "display": "Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "Alkaline phosphatase",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-20",
        "value": 236,
        "unit": "U/L",
        "reference_range": {
          "low": 35,
          "high": 104
        },
        "interpretation": "H",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6768-6",
            "display": "Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic chemistry at presentation: a cholestatic pattern and a raised random glucose.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-TBIL-V1",
        "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
        "label": "Total bilirubin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-20",
        "value": 1.6,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.1,
          "high": 1.2
        },
        "interpretation": "H",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1975-2",
            "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic chemistry at presentation: a cholestatic pattern and a raised random glucose.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-ALB-V1",
        "display": "Albumin [Mass/volume] in Serum or Plasma",
        "label": "Albumin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-20",
        "value": 3.6,
        "unit": "g/dL",
        "reference_range": {
          "low": 3.5,
          "high": 5.0
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1751-7",
            "display": "Albumin [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic chemistry at presentation: a cholestatic pattern and a raised random glucose.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-LIP-V1",
        "display": "Lipase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "Lipase",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-20",
        "value": 52,
        "unit": "U/L",
        "reference_range": {
          "low": 13,
          "high": 60
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "3040-3",
            "display": "Lipase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic lipase; normal, against pancreatitis.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-A1C-V1",
        "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
        "label": "Hemoglobin A1c",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-20",
        "value": 6.6,
        "unit": "%",
        "reference_range": {
          "high": 5.6,
          "text": "Below 5.7% is normal; 5.7 to 6.4% prediabetes; 6.5% or more diabetes"
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "4548-4",
            "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic A1c; in the diabetes range, new, in a lean young woman losing weight.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ2-V1",
        "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
        "label": "PHQ-2",
        "status": "final",
        "effective_date": "2026-04-20",
        "value": 1,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "55758-7",
            "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic depression screen; negative. Not a claim about her real mood.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-PAIN-V1",
        "display": "Pain severity - 0-10 verbal numeric rating [Score] - Reported",
        "label": "Pain score (0 to 10)",
        "status": "final",
        "effective_date": "2026-04-20",
        "value": 5,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "72514-3",
            "display": "Pain severity - 0-10 verbal numeric rating [Score] - Reported",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic pain score at presentation.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V2",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-04",
        "value": 10.4,
        "unit": "g/dL",
        "reference_range": {
          "low": 12.0,
          "high": 15.5
        },
        "interpretation": "L",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic blood count after intravenous iron and pantoprazole.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-WBC-V2",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White cell count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-04",
        "value": 7.0,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic blood count after intravenous iron and pantoprazole.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-ANC-V2",
        "display": "Neutrophils [#/volume] in Blood by Automated count",
        "label": "Absolute neutrophil count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-04",
        "value": 4.6,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 1.5,
          "high": 7.7
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "751-8",
            "display": "Neutrophils [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic blood count after intravenous iron and pantoprazole.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V2",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-04",
        "value": 366,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic blood count after intravenous iron and pantoprazole.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V2",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-04",
        "value": 0.68,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.59,
          "high": 1.04
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic chemistry a week after the biliary stent; the glucose is a fasting sample.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V2",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-04",
        "value": 119,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic chemistry a week after the biliary stent; the glucose is a fasting sample.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V2",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-04",
        "value": 141,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "H",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic chemistry a week after the biliary stent; the glucose is a fasting sample.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V2",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-04",
        "value": 30,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 35
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic chemistry a week after the biliary stent; the glucose is a fasting sample.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V2",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-04",
        "value": 28,
        "unit": "U/L",
        "reference_range": {
          "low": 8,
          "high": 35
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic chemistry a week after the biliary stent; the glucose is a fasting sample.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-ALP-V2",
        "display": "Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "Alkaline phosphatase",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-04",
        "value": 168,
        "unit": "U/L",
        "reference_range": {
          "low": 35,
          "high": 104
        },
        "interpretation": "H",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6768-6",
            "display": "Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic chemistry a week after the biliary stent; the glucose is a fasting sample.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-TBIL-V2",
        "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
        "label": "Total bilirubin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-04",
        "value": 0.9,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.1,
          "high": 1.2
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1975-2",
            "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic chemistry a week after the biliary stent; the glucose is a fasting sample.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-ALB-V2",
        "display": "Albumin [Mass/volume] in Serum or Plasma",
        "label": "Albumin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-04",
        "value": 3.5,
        "unit": "g/dL",
        "reference_range": {
          "low": 3.5,
          "high": 5.0
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1751-7",
            "display": "Albumin [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic chemistry a week after the biliary stent; the glucose is a fasting sample.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-CA199-V2",
        "display": "Cancer Ag 19-9 [Units/volume] in Serum or Plasma",
        "label": "CA 19-9",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-04",
        "value": 486,
        "unit": "U/mL",
        "reference_range": {
          "high": 35
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "24108-3",
            "display": "Cancer Ag 19-9 [Units/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic CA 19-9, drawn after the bilirubin returned to normal so that it can be read as a tumor marker.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-CEA-V2",
        "display": "Carcinoembryonic Ag [Mass/volume] in Serum or Plasma",
        "label": "CEA",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-04",
        "value": 3.9,
        "unit": "ng/mL",
        "reference_range": {
          "high": 3.0,
          "text": "Up to 3.0 ng/mL in non-smokers"
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2039-6",
            "display": "Carcinoembryonic Ag [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic CEA at diagnosis.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-INR-V2",
        "display": "INR in Platelet poor plasma by Coagulation assay",
        "label": "INR",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-04",
        "value": 1.0,
        "unit": "{INR}",
        "reference_range": {
          "low": 0.8,
          "high": 1.2
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6301-6",
            "display": "INR in Platelet poor plasma by Coagulation assay",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic INR before port placement.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V2",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-05-04",
        "value": 7,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-9 on the day the diagnosis was explained; item 9 scored 0. Not a claim about her real mood.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-GAD7-V2",
        "display": "Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]",
        "label": "GAD-7",
        "status": "final",
        "effective_date": "2026-05-04",
        "value": 8,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "70274-6",
            "display": "Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic GAD-7 on the day of the diagnosis.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-PAIN-V2",
        "display": "Pain severity - 0-10 verbal numeric rating [Score] - Reported",
        "label": "Pain score (0 to 10)",
        "status": "final",
        "effective_date": "2026-05-04",
        "value": 6,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "72514-3",
            "display": "Pain severity - 0-10 verbal numeric rating [Score] - Reported",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic pain score before an opioid was started.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V3",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-29",
        "value": 11.2,
        "unit": "g/dL",
        "reference_range": {
          "low": 12.0,
          "high": 15.5
        },
        "interpretation": "L",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic blood count before cycle 4, with pegfilgrastim after each cycle.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-WBC-V3",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White cell count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-29",
        "value": 8.9,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic blood count before cycle 4, with pegfilgrastim after each cycle.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-ANC-V3",
        "display": "Neutrophils [#/volume] in Blood by Automated count",
        "label": "Absolute neutrophil count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-29",
        "value": 5.8,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 1.5,
          "high": 7.7
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "751-8",
            "display": "Neutrophils [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic blood count before cycle 4, with pegfilgrastim after each cycle.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V3",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-29",
        "value": 214,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic blood count before cycle 4, with pegfilgrastim after each cycle.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V3",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-29",
        "value": 0.72,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.59,
          "high": 1.04
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic chemistry before cycle 4.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V3",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-29",
        "value": 114,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic chemistry before cycle 4.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V3",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-29",
        "value": 128,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "H",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic chemistry before cycle 4.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V3",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-29",
        "value": 26,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 35
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic chemistry before cycle 4.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V3",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-29",
        "value": 27,
        "unit": "U/L",
        "reference_range": {
          "low": 8,
          "high": 35
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic chemistry before cycle 4.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-ALP-V3",
        "display": "Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "Alkaline phosphatase",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-29",
        "value": 120,
        "unit": "U/L",
        "reference_range": {
          "low": 35,
          "high": 104
        },
        "interpretation": "H",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6768-6",
            "display": "Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic chemistry before cycle 4.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-TBIL-V3",
        "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
        "label": "Total bilirubin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-29",
        "value": 0.6,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.1,
          "high": 1.2
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1975-2",
            "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic chemistry before cycle 4.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-ALB-V3",
        "display": "Albumin [Mass/volume] in Serum or Plasma",
        "label": "Albumin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-29",
        "value": 3.5,
        "unit": "g/dL",
        "reference_range": {
          "low": 3.5,
          "high": 5.0
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1751-7",
            "display": "Albumin [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic chemistry before cycle 4.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-MG-V3",
        "display": "Magnesium [Mass/volume] in Serum or Plasma",
        "label": "Magnesium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-29",
        "value": 1.9,
        "unit": "mg/dL",
        "reference_range": {
          "low": 1.7,
          "high": 2.2
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "19123-9",
            "display": "Magnesium [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic magnesium before cycle 4.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-FERR-V3",
        "display": "Ferritin [Mass/volume] in Serum or Plasma",
        "label": "Ferritin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-29",
        "value": 88,
        "unit": "ng/mL",
        "reference_range": {
          "low": 15,
          "high": 150
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2276-4",
            "display": "Ferritin [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic ferritin eight weeks after intravenous iron.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-CA199-V3",
        "display": "Cancer Ag 19-9 [Units/volume] in Serum or Plasma",
        "label": "CA 19-9",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-29",
        "value": 210,
        "unit": "U/mL",
        "reference_range": {
          "high": 35
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "24108-3",
            "display": "Cancer Ag 19-9 [Units/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic CA 19-9 after three cycles; falling.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V3",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-06-29",
        "value": 8,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-9; item 9 scored 0.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-GAD7-V3",
        "display": "Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]",
        "label": "GAD-7",
        "status": "final",
        "effective_date": "2026-06-29",
        "value": 9,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "70274-6",
            "display": "Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic GAD-7.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-PAIN-V3",
        "display": "Pain severity - 0-10 verbal numeric rating [Score] - Reported",
        "label": "Pain score (0 to 10)",
        "status": "final",
        "effective_date": "2026-06-29",
        "value": 2,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "72514-3",
            "display": "Pain severity - 0-10 verbal numeric rating [Score] - Reported",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic pain score on a low opioid dose.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V6",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-16",
        "value": 11.0,
        "unit": "g/dL",
        "reference_range": {
          "low": 12.0,
          "high": 15.5
        },
        "interpretation": "L",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic blood count at the sick visit; no neutropenia.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-WBC-V6",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White cell count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-16",
        "value": 6.2,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic blood count at the sick visit; no neutropenia.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-ANC-V6",
        "display": "Neutrophils [#/volume] in Blood by Automated count",
        "label": "Absolute neutrophil count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-16",
        "value": 4.1,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 1.5,
          "high": 7.7
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "751-8",
            "display": "Neutrophils [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic blood count at the sick visit; no neutropenia.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V6",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-16",
        "value": 188,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic blood count at the sick visit; no neutropenia.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-NA-V6",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-16",
        "value": 134,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "L",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic chemistry at the sick visit: low potassium and sodium from diarrhea, creatinine up from her baseline.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-K-V6",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-16",
        "value": 3.2,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "L",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic chemistry at the sick visit: low potassium and sodium from diarrhea, creatinine up from her baseline.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V6",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-16",
        "value": 0.94,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.59,
          "high": 1.04
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic chemistry at the sick visit: low potassium and sodium from diarrhea, creatinine up from her baseline.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V6",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-16",
        "value": 83,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic chemistry at the sick visit: low potassium and sodium from diarrhea, creatinine up from her baseline.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V6",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-16",
        "value": 118,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "H",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic chemistry at the sick visit: low potassium and sodium from diarrhea, creatinine up from her baseline.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-MG-V6",
        "display": "Magnesium [Mass/volume] in Serum or Plasma",
        "label": "Magnesium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-16",
        "value": 1.6,
        "unit": "mg/dL",
        "reference_range": {
          "low": 1.7,
          "high": 2.2
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "19123-9",
            "display": "Magnesium [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic magnesium at the sick visit; low.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V4",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-10",
        "value": 10.9,
        "unit": "g/dL",
        "reference_range": {
          "low": 12.0,
          "high": 15.5
        },
        "interpretation": "L",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic blood count two weeks after cycle 6.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-WBC-V4",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White cell count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-10",
        "value": 7.8,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic blood count two weeks after cycle 6.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-ANC-V4",
        "display": "Neutrophils [#/volume] in Blood by Automated count",
        "label": "Absolute neutrophil count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-10",
        "value": 4.9,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 1.5,
          "high": 7.7
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "751-8",
            "display": "Neutrophils [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic blood count two weeks after cycle 6.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V4",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-10",
        "value": 176,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic blood count two weeks after cycle 6.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-NA-V4",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-10",
        "value": 138,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic chemistry before surgery.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-K-V4",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-10",
        "value": 4.1,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic chemistry before surgery.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V4",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-10",
        "value": 0.76,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.59,
          "high": 1.04
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic chemistry before surgery.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V4",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-10",
        "value": 107,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic chemistry before surgery.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V4",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-10",
        "value": 124,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "H",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic chemistry before surgery.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V4",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-10",
        "value": 24,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 35
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic chemistry before surgery.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V4",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-10",
        "value": 26,
        "unit": "U/L",
        "reference_range": {
          "low": 8,
          "high": 35
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic chemistry before surgery.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-ALP-V4",
        "display": "Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "Alkaline phosphatase",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-10",
        "value": 98,
        "unit": "U/L",
        "reference_range": {
          "low": 35,
          "high": 104
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6768-6",
            "display": "Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic chemistry before surgery.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-TBIL-V4",
        "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
        "label": "Total bilirubin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-10",
        "value": 0.5,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.1,
          "high": 1.2
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1975-2",
            "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic chemistry before surgery.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-ALB-V4",
        "display": "Albumin [Mass/volume] in Serum or Plasma",
        "label": "Albumin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-10",
        "value": 3.6,
        "unit": "g/dL",
        "reference_range": {
          "low": 3.5,
          "high": 5.0
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1751-7",
            "display": "Albumin [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic chemistry before surgery.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-A1C-V4",
        "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
        "label": "Hemoglobin A1c",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-10",
        "value": 7.0,
        "unit": "%",
        "reference_range": {
          "high": 5.6,
          "text": "Below 5.7% is normal; 5.7 to 6.4% prediabetes; 6.5% or more diabetes"
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "4548-4",
            "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic A1c about three and a half months after the diabetes diagnosis.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-CA199-V4",
        "display": "Cancer Ag 19-9 [Units/volume] in Serum or Plasma",
        "label": "CA 19-9",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-10",
        "value": 41,
        "unit": "U/mL",
        "reference_range": {
          "high": 35
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "24108-3",
            "display": "Cancer Ag 19-9 [Units/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic CA 19-9 after six cycles; near normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-INR-V4",
        "display": "INR in Platelet poor plasma by Coagulation assay",
        "label": "INR",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-10",
        "value": 1.0,
        "unit": "{INR}",
        "reference_range": {
          "low": 0.8,
          "high": 1.2
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6301-6",
            "display": "INR in Platelet poor plasma by Coagulation assay",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic INR before surgery.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V4",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-08-10",
        "value": 6,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-9; item 9 scored 0.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-PAIN-V4",
        "display": "Pain severity - 0-10 verbal numeric rating [Score] - Reported",
        "label": "Pain score (0 to 10)",
        "status": "final",
        "effective_date": "2026-08-10",
        "value": 1,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "72514-3",
            "display": "Pain severity - 0-10 verbal numeric rating [Score] - Reported",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic pain score.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V5",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-05",
        "value": 10.6,
        "unit": "g/dL",
        "reference_range": {
          "low": 12.0,
          "high": 15.5
        },
        "interpretation": "L",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic blood count six weeks after surgery.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-WBC-V5",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White cell count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-05",
        "value": 8.2,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic blood count six weeks after surgery.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-ANC-V5",
        "display": "Neutrophils [#/volume] in Blood by Automated count",
        "label": "Absolute neutrophil count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-05",
        "value": 5.1,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 1.5,
          "high": 7.7
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "751-8",
            "display": "Neutrophils [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic blood count six weeks after surgery.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V5",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-05",
        "value": 302,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic blood count six weeks after surgery.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-NA-V5",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-05",
        "value": 137,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic chemistry six weeks after surgery.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-K-V5",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-05",
        "value": 4.3,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic chemistry six weeks after surgery.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V5",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-05",
        "value": 0.71,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.59,
          "high": 1.04
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic chemistry six weeks after surgery.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V5",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-05",
        "value": 116,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic chemistry six weeks after surgery.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V5",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-05",
        "value": 156,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "H",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic chemistry six weeks after surgery.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V5",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-05",
        "value": 22,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 35
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic chemistry six weeks after surgery.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V5",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-05",
        "value": 24,
        "unit": "U/L",
        "reference_range": {
          "low": 8,
          "high": 35
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic chemistry six weeks after surgery.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-ALP-V5",
        "display": "Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "Alkaline phosphatase",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-05",
        "value": 110,
        "unit": "U/L",
        "reference_range": {
          "low": 35,
          "high": 104
        },
        "interpretation": "H",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6768-6",
            "display": "Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic chemistry six weeks after surgery.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-TBIL-V5",
        "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
        "label": "Total bilirubin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-05",
        "value": 0.5,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.1,
          "high": 1.2
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1975-2",
            "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic chemistry six weeks after surgery.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-ALB-V5",
        "display": "Albumin [Mass/volume] in Serum or Plasma",
        "label": "Albumin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-05",
        "value": 3.4,
        "unit": "g/dL",
        "reference_range": {
          "low": 3.5,
          "high": 5.0
        },
        "interpretation": "L",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1751-7",
            "display": "Albumin [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic chemistry six weeks after surgery.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-CA199-V5",
        "display": "Cancer Ag 19-9 [Units/volume] in Serum or Plasma",
        "label": "CA 19-9",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-05",
        "value": 18,
        "unit": "U/mL",
        "reference_range": {
          "high": 35
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "24108-3",
            "display": "Cancer Ag 19-9 [Units/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic CA 19-9 after surgery; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V5",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-10-05",
        "value": 7,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-9; item 9 scored 0.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-GAD7-V5",
        "display": "Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]",
        "label": "GAD-7",
        "status": "final",
        "effective_date": "2026-10-05",
        "value": 6,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "70274-6",
            "display": "Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic GAD-7.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-PAIN-V5",
        "display": "Pain severity - 0-10 verbal numeric rating [Score] - Reported",
        "label": "Pain score (0 to 10)",
        "status": "final",
        "effective_date": "2026-10-05",
        "value": 2,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "72514-3",
            "display": "Pain severity - 0-10 verbal numeric rating [Score] - Reported",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic pain score after surgery.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V7",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-10-21",
        "value": 5,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-9 at the preventive visit; item 9 scored 0. Not a claim about her real mood.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-UACR-V5",
        "display": "Albumin/Creatinine [Mass Ratio] in Urine",
        "label": "Urine albumin-to-creatinine ratio",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-05",
        "value": 12,
        "unit": "mg/g",
        "reference_range": {
          "high": 30
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "9318-7",
            "display": "Albumin/Creatinine [Mass Ratio] in Urine",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic urine albumin for diabetes care, drawn late (see the deviation recorded at this visit).",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:30:00-05:00"
        }
      }
    ],
    "procedures": [
      {
        "id": "PROC-001",
        "display": "Upper endoscopy with biopsy, under sedation: no gastric or duodenal ulcer; a friable, ulcerated mass on the medial wall of the second part of the duodenum next to the major papilla, oozing slowly; four biopsies taken; hemostasis with epinephrine injection",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "445982009",
            "display": "Endoscopy and biopsy of upper gastrointestinal tract",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-04-22",
          "end": "2026-04-22"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic endoscopy two days after the first visit.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "PROC-002",
        "display": "Pancreas-protocol CT of the abdomen and pelvis with contrast (arterial and portal venous phases), with CT of the chest: a 3.1 cm hypoattenuating mass in the head of the pancreas invading the duodenal wall; dilated common bile duct (13 mm) and pancreatic duct (5 mm); tumor contact with about 200 degrees of the superior mesenteric vein with short-segment narrowing that can be reconstructed; no contact with the superior mesenteric artery, celiac axis or common hepatic artery; no liver, peritoneal or lung lesion; no ascites",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "432370003",
            "display": "Computed tomography of abdomen and pelvis with contrast",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-04-23",
          "end": "2026-04-23"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic staging CT three days after the first visit.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "PROC-003",
        "display": "Endoscopic ultrasound with fine-needle biopsy of the pancreatic head mass (three passes with a 22-gauge biopsy needle): 3.2 cm hypoechoic mass invading the duodenum and abutting the portal confluence; no ascites; rapid on-site evaluation adequate; extra cores sent for tumor molecular profiling",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "788641000",
            "display": "Endoscopic ultrasonography guided fine needle aspiration of pancreatic lesion",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-04-27",
          "end": "2026-04-27"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic tissue diagnosis.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "PROC-004",
        "display": "ERCP in the same session with placement of a fully covered self-expanding metal stent (10 mm by 60 mm) across a distal common bile duct stricture; good drainage of bile",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "83735008",
            "display": "Insertion of biliary stent by ERCP",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-04-27",
          "end": "2026-04-27"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic biliary drainage before chemotherapy; a metal stent is preferred when chemotherapy before surgery is planned.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "PROC-005",
        "display": "Pancreatic multidisciplinary tumor board (surgical oncology, medical oncology, radiation oncology, gastroenterology, radiology, pathology, palliative care, nurse navigator): borderline resectable pancreatic head adenocarcinoma (venous involvement); recommends chemotherapy before surgery with modified FOLFIRINOX, restaging, then resection if there is no progression",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "384682003",
            "display": "Multidisciplinary care conference",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-04-29",
          "end": "2026-04-29"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic tumor board review.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "PROC-010",
        "display": "Advance care planning conversation, about 30 minutes",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "713603004",
            "display": "Advance care planning",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-10-21",
          "end": "2026-10-21"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic voluntary advance care planning; records only her own general preferences.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "PROC-006",
        "display": "Genetic counseling before germline testing: three-generation pedigree, consent, and explanation of what a positive or negative result would mean for her and her blood relatives",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "79841006",
            "display": "Genetic counseling",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-05-04",
          "end": "2026-05-04"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic genetic counseling for every patient with pancreatic cancer.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:30:00-05:00"
        }
      },
      {
        "id": "PROC-007",
        "display": "Outpatient palliative care consultation, two days after the diagnosis visit: symptom review, a serious illness conversation about her hopes, worries and what matters most (her writing and a clear head), and a plan for pain, appetite and sleep alongside cancer treatment",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "103735009",
            "display": "Palliative care",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-05-06",
          "end": "2026-05-06"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic early palliative care.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:30:00-05:00"
        }
      },
      {
        "id": "PROC-008",
        "display": "Restaging pancreas-protocol CT of the abdomen and pelvis with contrast, with CT of the chest, after six cycles: pancreatic head mass smaller (2.1 cm from 3.1 cm); contact with the superior mesenteric vein reduced to about 150 degrees; no arterial contact; biliary stent in place; no liver, peritoneal or lung lesion",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "432370003",
            "display": "Computed tomography of abdomen and pelvis with contrast",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-08-06",
          "end": "2026-08-06"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic restaging imaging.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:30:00-05:00"
        }
      },
      {
        "id": "PROC-009",
        "display": "Open pylorus-preserving pancreaticoduodenectomy with segmental resection of the superior mesenteric vein and primary venous repair, and removal of the biliary stent: pathology ypT2N1 (2.3 cm residual adenocarcinoma; 2 of 18 lymph nodes involved; perineural invasion), all margins clear (R0), partial treatment response (CAP tumor regression score 2); nine days in hospital, with mild delayed gastric emptying that settled",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "116242006",
            "display": "Pylorus-sparing pancreaticoduodenectomy",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-08-24",
          "end": "2026-08-24"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic operation after restaging; the date maps to the month of her documented surgery in Boston, which this does not claim to describe.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:30:00-05:00"
        }
      }
    ],
    "immunizations": [
      {
        "id": "IMM-001",
        "display": "Tdap vaccine",
        "status": "completed",
        "date": "2022-09-12",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "115",
            "display": "Tdap",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic adult immunization history in the modern frame; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "IMM-002",
        "display": "Pneumococcal conjugate vaccine (PCV20), before chemotherapy",
        "status": "completed",
        "date": "2026-05-04",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "216",
            "display": "Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic pneumococcal vaccination for an adult about to receive immunosuppressive chemotherapy.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "IMM-003",
        "display": "Recombinant zoster vaccine, dose 1 of 2, before chemotherapy",
        "status": "completed",
        "date": "2026-05-04",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "187",
            "display": "zoster recombinant",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic first zoster dose for an adult about to receive immunosuppressive chemotherapy.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "IMM-004",
        "display": "Recombinant zoster vaccine, dose 2 of 2",
        "status": "completed",
        "date": "2026-06-29",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "187",
            "display": "zoster recombinant",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic second zoster dose, eight weeks after the first.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "IMM-005",
        "display": "Influenza vaccine, this season (inactivated)",
        "status": "completed",
        "date": "2026-10-21",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "140",
            "display": "Influenza, split virus, trivalent, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic yearly influenza vaccination, given between chemotherapy cycles.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "IMM-006",
        "display": "COVID-19 mRNA vaccine, this season's formula",
        "status": "completed",
        "date": "2026-10-21",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "309",
            "display": "COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mL",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seasonal COVID-19 vaccination.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      }
    ],
    "family_history": [
      {
        "id": "FH-001",
        "relationship": {
          "system": "http://terminology.hl7.org/CodeSystem/v3-RoleCode",
          "code": "FTH",
          "display": "father"
        },
        "condition": "Died suddenly of a cerebral hemorrhage when she was sixteen; no cancer recorded in the cited source",
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0003"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      }
    ],
    "past_medical_history": [],
    "encounters": [
      {
        "id": "ENC-001",
        "display": "Two months of epigastric and back pain, weight loss, black stools and near-fainting in a woman of 32: examination, blood tests, and urgent upper endoscopy and pancreas-protocol CT",
        "status": "finished",
        "date": "2026-04-20",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "ENC-002",
        "display": "Diagnosis of pancreatic adenocarcinoma: tumor board plan, medical oncology consultation, genetic counseling, early palliative care, and planning of chemotherapy before surgery",
        "status": "finished",
        "date": "2026-05-04",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "Diagnosis visit: biopsy results, the tumor board plan, and the oncology consultation",
          "hpi": {
            "narrative": "Ms. Hansberry returns two weeks after her first visit. Upper endoscopy two days after that visit found no ulcer but an ulcerated mass in the duodenum next to the papilla, oozing slowly, and the biopsies show adenocarcinoma. The pancreas-protocol CT the next day showed a 3.1 cm mass in the head of the pancreas invading the duodenum, with dilated bile and pancreatic ducts and contact with more than half the circumference of the superior mesenteric vein, but no contact with the arteries and no spread to the liver, peritoneum or lungs. Endoscopic ultrasound a week ago confirmed pancreatic adenocarcinoma on biopsy, and a metal stent was placed in the bile duct at the same session; her urine is lighter and the itching has gone. The tumor board reviewed her five days ago. She had two doses of intravenous iron and has had no more black stools. Pain in the upper abdomen and back is 6 out of 10 and wakes her. Her stools are pale and float after fatty meals. She saw Dr. Adeyemi-Rourke this morning and genetic counseling this afternoon. She asked to be told everything plainly and was. She has had no thoughts of self-harm.",
            "elements": [
              {
                "label": "Diagnosis",
                "value": "Adenocarcinoma of the head of the pancreas invading the duodenum; borderline resectable (venous contact more than 180 degrees, no arterial contact); no distant spread"
              },
              {
                "label": "Procedures since the first visit",
                "value": "Upper endoscopy with biopsy; pancreas-protocol CT; EUS-guided biopsy; ERCP with a metal biliary stent; two doses of intravenous iron"
              },
              {
                "label": "Tumor board",
                "value": "Modified FOLFIRINOX before surgery, restaging, then resection if no progression"
              },
              {
                "label": "Symptoms",
                "value": "Pain 6 out of 10; pale floating stools; no more black stools; itching gone"
              },
              {
                "label": "Her questions",
                "value": "Whether this can be cured; whether she can keep writing; what the genetic test means for her family; whether she could still have children"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Tired; weight 55.4 kg, down 0.8 kg in two weeks; no fever"
            },
            {
              "system": "Gastrointestinal",
              "status": "positive",
              "finding": "Upper abdominal and back pain; pale, floating stools after fatty meals; no black stools since the iron; nausea mild"
            },
            {
              "system": "Integumentary",
              "status": "negative",
              "finding": "Itching gone after the stent; no rash"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No more near-fainting; no leg swelling"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "Urine lighter; last period two weeks ago"
            },
            {
              "system": "Psychiatric",
              "status": "positive",
              "finding": "Shaken by the diagnosis and determined; PHQ-9 7, GAD-7 8; no thoughts of self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Thin, tired, composed; weight 55.4 kg; blood pressure 108/68, pulse 92"
            },
            {
              "system": "Eyes",
              "finding": "Slight scleral icterus, less than at the first visit"
            },
            {
              "system": "Abdomen",
              "finding": "Tender in the epigastrium without guarding; no mass felt; no liver enlargement; no ascites"
            },
            {
              "system": "Lymph nodes",
              "finding": "No supraclavicular nodes; no umbilical nodule"
            },
            {
              "system": "Extremities",
              "finding": "No calf tenderness or leg swelling"
            },
            {
              "system": "Psychiatric",
              "finding": "Direct, asks exact questions, writes down the answers; tearful briefly"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-004",
              "display": "Adenocarcinoma of the head of the pancreas, borderline resectable",
              "assessment": "Pancreatic adenocarcinoma diagnosed two weeks after she first came, because the pain with weight loss, the anemia and the new diabetes were investigated at once rather than put down to stress. It is borderline resectable because of the venous contact, with no arterial involvement and no distant spread. The tumor board and Dr. Adeyemi-Rourke recommend modified FOLFIRINOX before surgery, which she is fit for (ECOG 1, normal kidney and liver function now that the bile is draining), then restaging and resection. CA 19-9 is 486 U/mL, measured after the bilirubin came down so that it reflects the tumor. She was told plainly that the aim is cure, that surgery after chemotherapy offers the best chance, and that the cancer can still return",
              "plan": [
                "Port placement next week; cycle 1 of modified FOLFIRINOX in two weeks",
                "Hepatitis B, hepatitis C and HIV tests drawn today; urine pregnancy test negative today",
                "Germline multigene panel sent after counseling; tumor molecular profiling on the EUS cores",
                "PCV20 and the first recombinant zoster vaccine given today, before chemotherapy"
              ]
            },
            {
              "problem_id": "PRB-007",
              "display": "Cancer-related pain",
              "assessment": "Pain 6 out of 10 from the tumor, breaking her sleep. She wants a clear head for writing, so the plan starts low",
              "plan": [
                "Oxycodone 5 mg every 4 hours as needed, with senna",
                "Palliative care consultation in two days",
                "EUS-guided celiac plexus neurolysis if pain becomes severe"
              ]
            },
            {
              "problem_id": "PRB-006",
              "display": "Exocrine pancreatic insufficiency",
              "assessment": "Pale, floating stools and weight loss from the blocked pancreatic duct; enzyme replacement is started on clinical grounds",
              "plan": [
                "Pancrelipase two capsules (72,000 lipase units) with meals and one with snacks",
                "Dietitian review this week"
              ]
            },
            {
              "problem_id": "PRB-005",
              "display": "Diabetes due to the pancreatic cancer",
              "assessment": "Fasting glucose 141 mg/dL today confirms the A1c of 6.6% from the first visit. This is diabetes caused by the pancreatic disease, not type 2: weight loss and enzyme loss come with it, and insulin, not a drug that causes weight loss, is the treatment if one is needed",
              "plan": [
                "Home glucose meter and teaching",
                "No glucose-lowering drug yet",
                "Dexamethasone limited to day 1 of each cycle",
                "Dilated eye examination and urine albumin-to-creatinine ratio to be arranged"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Iron deficiency anemia from blood loss",
              "assessment": "Hemoglobin up from 9.1 to 10.4 g/dL after two doses of intravenous iron; no bleeding since",
              "plan": [
                "Continue pantoprazole",
                "Ferritin with the cycle 4 blood tests"
              ]
            },
            {
              "problem_id": "PRB-001",
              "display": "Epigastric pain with weight loss",
              "assessment": "Explained by the diagnosis made today; superseded",
              "plan": [
                "Problem resolved"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "New hyperglycemia",
              "assessment": "Confirmed as diabetes due to the pancreatic cancer; superseded",
              "plan": [
                "Problem resolved"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "laboratory",
              "measure": "Tissue diagnosis",
              "cadence": "Before treatment",
              "status": "up_to_date",
              "detail": "EUS-guided biopsy: adenocarcinoma of the pancreas, moderately differentiated; duodenal biopsies: adenocarcinoma invading from the pancreas",
              "guideline_ids": [
                "GL-NCCN-PANC-2026",
                "GL-ASCO-PANC-2016"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Pancreas-protocol CT of the abdomen with CT of the chest",
              "cadence": "At diagnosis, before any treatment",
              "status": "up_to_date",
              "detail": "Borderline resectable: superior mesenteric vein contact about 200 degrees with reconstructible narrowing; no arterial contact; no metastases",
              "guideline_ids": [
                "GL-NCCN-PANC-2026",
                "GL-ASCO-PANC-2016"
              ]
            },
            {
              "domain": "referral",
              "measure": "Pancreatic multidisciplinary tumor board",
              "cadence": "Before treatment for every localized pancreatic cancer",
              "status": "up_to_date",
              "detail": "Five days ago: modified FOLFIRINOX first, restaging, then resection",
              "guideline_ids": [
                "GL-NCCN-PANC-2026",
                "GL-ASCO-PANC-2016"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Biliary drainage and liver tests",
              "cadence": "Before chemotherapy when the bile duct is blocked",
              "status": "completed_today",
              "detail": "Metal stent placed a week ago; bilirubin 0.9 mg/dL (from 1.6), alkaline phosphatase 168 U/L, ALT 30 U/L, AST 28 U/L, albumin 3.5 g/dL",
              "observation_ids": [
                "OBS-TBIL-V2",
                "OBS-ALP-V2",
                "OBS-ALT-V2",
                "OBS-AST-V2",
                "OBS-ALB-V2"
              ],
              "guideline_ids": [
                "GL-NCCN-PANC-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "CA 19-9",
              "cadence": "At diagnosis after biliary drainage, every two cycles during treatment, before surgery, after surgery, then every three to six months",
              "status": "completed_today",
              "detail": "486 U/mL, drawn after biliary drainage so that it is not falsely raised by jaundice; CEA 3.9 ng/mL",
              "observation_ids": [
                "OBS-CA199-V2",
                "OBS-CEA-V2"
              ],
              "guideline_ids": [
                "GL-NCCN-PANC-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Blood count with neutrophils and platelets",
              "cadence": "Before each chemotherapy cycle and at each visit",
              "status": "completed_today",
              "detail": "Hemoglobin 10.4 g/dL, white cells 7.0, neutrophils 4.6, platelets 366",
              "observation_ids": [
                "OBS-HGB-V2",
                "OBS-WBC-V2",
                "OBS-ANC-V2",
                "OBS-PLT-V2"
              ],
              "guideline_ids": [
                "GL-NCCN-PANC-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Kidney function before chemotherapy",
              "cadence": "Before each cycle",
              "status": "completed_today",
              "detail": "Creatinine 0.68 mg/dL, eGFR 119",
              "observation_ids": [
                "OBS-CR-V2",
                "OBS-EGFR-V2"
              ],
              "guideline_ids": [
                "GL-NCCN-PANC-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "INR before port placement",
              "cadence": "Before the procedure",
              "status": "completed_today",
              "detail": "1.0",
              "observation_ids": [
                "OBS-INR-V2"
              ],
              "guideline_ids": [
                "GL-NCCN-PANC-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Hepatitis B, hepatitis C and HIV screening",
              "cadence": "Before chemotherapy",
              "status": "ordered",
              "detail": "Hepatitis B surface antigen, core antibody and surface antibody, hepatitis C antibody and HIV drawn today",
              "guideline_ids": [
                "GL-ASCO-HBV-2020"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Pregnancy test",
              "cadence": "Before chemotherapy",
              "status": "completed_today",
              "detail": "Urine pregnancy test negative",
              "guideline_ids": [
                "GL-ASCO-FERT-2018"
              ]
            },
            {
              "domain": "referral",
              "measure": "Genetic counseling",
              "cadence": "At diagnosis of pancreatic cancer",
              "status": "completed_today",
              "detail": "Pedigree taken; no known pancreatic, breast, ovarian, prostate or colorectal cancer in her family; consent given",
              "guideline_ids": [
                "GL-ASCO-PANCGERM-2019",
                "GL-NCCN-PANC-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Germline multigene panel",
              "cadence": "Once, at diagnosis, for every patient with pancreatic cancer",
              "status": "ordered",
              "detail": "Includes BRCA1, BRCA2, PALB2, ATM, CDKN2A, the Lynch syndrome genes, STK11 and TP53; result in about three weeks",
              "guideline_ids": [
                "GL-ASCO-PANCGERM-2019",
                "GL-NCCN-PANC-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Tumor molecular profiling",
              "cadence": "At diagnosis, on tissue",
              "status": "ordered",
              "detail": "Next-generation sequencing on the EUS cores, with mismatch repair status and fusion testing",
              "guideline_ids": [
                "GL-NCCN-PANC-2026",
                "GL-ASCO-MPC-2020"
              ]
            },
            {
              "domain": "referral",
              "measure": "Fertility counseling",
              "cadence": "Before gonadotoxic chemotherapy",
              "status": "completed_today",
              "detail": "Oxaliplatin and irinotecan may reduce fertility. Egg or embryo freezing would delay chemotherapy by about two weeks; she chose not to delay treatment, which was respected. Effective non-estrogen contraception advised",
              "guideline_ids": [
                "GL-ASCO-FERT-2018"
              ]
            },
            {
              "domain": "referral",
              "measure": "Palliative care",
              "cadence": "From diagnosis, alongside cancer treatment",
              "status": "referred",
              "detail": "Outpatient palliative care consultation in two days",
              "guideline_ids": [
                "GL-ASCO-PALL-2024"
              ]
            },
            {
              "domain": "survey",
              "measure": "Pain score and opioid review",
              "cadence": "Each visit",
              "status": "completed_today",
              "detail": "Pain 6 out of 10; oxycodone 5 mg as needed started with senna",
              "observation_ids": [
                "OBS-PAIN-V2"
              ],
              "guideline_ids": [
                "GL-ASCO-PALL-2024"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Weight, nutrition and enzyme replacement",
              "cadence": "Each visit",
              "status": "completed_today",
              "detail": "Weight 55.4 kg; pancrelipase started; dietitian referral this week",
              "guideline_ids": [
                "GL-NCCN-PANC-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Glucose and home readings",
              "cadence": "Each visit and before each cycle",
              "status": "completed_today",
              "detail": "Fasting glucose 141 mg/dL: with the A1c of 6.6%, diabetes is confirmed",
              "observation_ids": [
                "OBS-GLU-V2"
              ],
              "guideline_ids": [
                "GL-ADA-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Dilated eye examination and urine albumin-to-creatinine ratio",
              "cadence": "At diagnosis of diabetes, then yearly",
              "status": "due",
              "detail": "To be arranged now that diabetes is confirmed",
              "guideline_ids": [
                "GL-ADA-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Venous thromboembolism risk (Khorana score)",
              "cadence": "At the start of chemotherapy",
              "status": "completed_today",
              "detail": "Khorana score 3 (pancreatic primary, hemoglobin under 10 g/dL at the first visit). Primary prophylaxis with apixaban is recommended for this score, but it is held for now because the duodenal tumor bled within the last month; to start when there has been no bleeding for several weeks",
              "guideline_ids": [
                "GL-ASCO-VTE-2023",
                "GL-AVERT-2019"
              ]
            },
            {
              "domain": "survey",
              "measure": "Distress and depression screen (PHQ-9, GAD-7)",
              "cadence": "At diagnosis, at each treatment phase, and when symptoms change",
              "status": "completed_today",
              "detail": "PHQ-9 7 and GAD-7 8, mild, with fear about the diagnosis; no thoughts of self-harm",
              "observation_ids": [
                "OBS-PHQ9-V2",
                "OBS-GAD7-V2"
              ],
              "guideline_ids": [
                "GL-USPSTF-DEP-2023",
                "GL-ASCO-PALL-2024"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Plain information and support she chooses",
              "cadence": "At diagnosis and throughout",
              "status": "completed_today",
              "detail": "Plain explanation of the diagnosis, its stage and the aim of treatment, with written information; she chose who would be told and who receives her notes",
              "guideline_ids": [
                "GL-USPSTF-DEP-2023",
                "GL-ASCO-PALL-2024"
              ]
            }
          ],
          "follow_up": "Palliative care in two days; port next week; cycle 1 in two weeks. Primary care review at cycle 4. Call at once for fever, yellow eyes, black stools, fainting, or leg swelling",
          "guideline_ids": [
            "GL-NCCN-PANC-2026",
            "GL-ASCO-PANC-2016",
            "GL-ASCO-PANCGERM-2019",
            "GL-ASCO-PALL-2024",
            "GL-ASCO-VTE-2023",
            "GL-ASCO-HBV-2020",
            "GL-ASCO-FERT-2018",
            "GL-ADA-2026",
            "GL-NOEL-2019",
            "GL-USPSTF-DEP-2023"
          ]
        }
      },
      {
        "id": "ENC-003",
        "display": "Day 1 of cycle 4 of modified FOLFIRINOX: toxicity review, genetic and tumor profiling results, thromboprophylaxis, nutrition and mood",
        "status": "finished",
        "date": "2026-06-29",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "Review on day 1 of cycle 4 of modified FOLFIRINOX",
          "hpi": {
            "narrative": "Ms. Hansberry returns on the first day of her fourth cycle; cycles 1 to 3 were given on schedule. After each cycle she has nausea for a day or two, controlled with olanzapine at night, and two or three loose stools on days 3 to 5, settled with loperamide. For a few days after each cycle cold drinks hurt her throat and her fingers and toes tingle in the cold, and the fingertips now tingle mildly between cycles; she can still type and do buttons. Pain is 2 out of 10 with one or two oxycodone tablets a day, and she sleeps through. She writes three mornings a week. Her stools are formed with pancrelipase and her weight is steady. Home fasting glucose readings are 110 to 130 mg/dL. She has had no bleeding or black stools since the iron. The germline panel and the tumor profile have both resulted. She has had no thoughts of self-harm.",
            "elements": [
              {
                "label": "Treatment",
                "value": "Cycles 1 to 3 on schedule; cycle 4 today"
              },
              {
                "label": "Effects",
                "value": "Nausea one or two days; loose stools days 3 to 5; cold-induced tingling, now mild between cycles"
              },
              {
                "label": "Genetic results",
                "value": "Germline panel negative; tumor KRAS G12D, TP53 and CDKN2A alterations, microsatellite stable, no BRCA1, BRCA2 or PALB2 variant, no NTRK, NRG1 or ALK fusion"
              },
              {
                "label": "Pain",
                "value": "2 out of 10 on oxycodone once or twice a day"
              },
              {
                "label": "Writing",
                "value": "Three mornings a week"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Tired for three days after each cycle; weight 54.8 kg; no fever"
            },
            {
              "system": "Gastrointestinal",
              "status": "positive",
              "finding": "Nausea one or two days per cycle; loose stools days 3 to 5; no black stools"
            },
            {
              "system": "Neurological",
              "status": "positive",
              "finding": "Cold-induced tingling after each cycle; mild fingertip tingling between cycles; no weakness"
            },
            {
              "system": "Hematologic and lymphatic",
              "status": "negative",
              "finding": "No bleeding or bruising"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No leg swelling or calf pain"
            },
            {
              "system": "Psychiatric",
              "status": "positive",
              "finding": "Worried before each scan and test; PHQ-9 8, GAD-7 9; no thoughts of self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; weight 54.8 kg; blood pressure 110/70, pulse 84"
            },
            {
              "system": "Eyes",
              "finding": "No icterus"
            },
            {
              "system": "Abdomen",
              "finding": "Mild epigastric tenderness; port site clean"
            },
            {
              "system": "Neurological",
              "finding": "Light touch slightly reduced at the fingertips; vibration sense and reflexes normal; fine finger movements normal (grade 1 sensory neuropathy)"
            },
            {
              "system": "Extremities",
              "finding": "No leg swelling"
            },
            {
              "system": "Psychiatric",
              "finding": "Engaged, dry humor, organized"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-004",
              "display": "Pancreatic head adenocarcinoma, borderline resectable, on modified FOLFIRINOX",
              "assessment": "Responding by marker: CA 19-9 210 U/mL from 486. The germline panel is negative, so there is no inherited variant to pass on and no reason for platinum or PARP inhibitor choices based on one; the tumor carries the usual KRAS G12D change with no targetable alteration, so modified FOLFIRINOX remains the right treatment. Counts, kidney and liver function allow full doses today: neutrophils 5.8 with pegfilgrastim, platelets 214, creatinine 0.72 mg/dL, bilirubin 0.6 mg/dL. Hepatitis B, hepatitis C and HIV tests before cycle 1 were negative",
              "plan": [
                "Cycle 4 at full dose today",
                "Interim restaging CT in two weeks, before cycle 5",
                "Second recombinant zoster dose given today"
              ]
            },
            {
              "problem_id": "PRB-009",
              "display": "Oxaliplatin neuropathy, grade 1",
              "assessment": "Grade 1 sensory neuropathy, persisting mildly between cycles. No drug prevents it; the dose is continued at grade 1 and reduced or stopped if it reaches grade 2 or affects her hands",
              "plan": [
                "Avoid cold drinks and use gloves for the days after each cycle",
                "Check before each oxaliplatin dose"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Iron deficiency anemia from blood loss",
              "assessment": "Hemoglobin 11.2 g/dL and ferritin 88 ng/mL: iron stores replaced; no bleeding for eight weeks",
              "plan": [
                "Blood count with each cycle"
              ]
            },
            {
              "problem_id": "PRB-005",
              "display": "Diabetes due to the pancreatic cancer",
              "assessment": "Glucose 128 mg/dL; home fasting readings 110 to 130; no treatment needed yet",
              "plan": [
                "A1c with the restaging tests"
              ]
            },
            {
              "problem_id": "PRB-007",
              "display": "Cancer-related pain",
              "assessment": "Controlled: 2 out of 10 on one or two oxycodone tablets a day, with a clear head",
              "plan": [
                "Continue; review with palliative care monthly"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "laboratory",
              "measure": "Blood count with neutrophils and platelets",
              "cadence": "Before each chemotherapy cycle and at each visit",
              "status": "completed_today",
              "detail": "Hemoglobin 11.2 g/dL, white cells 8.9, neutrophils 5.8, platelets 214; full dose",
              "observation_ids": [
                "OBS-HGB-V3",
                "OBS-WBC-V3",
                "OBS-ANC-V3",
                "OBS-PLT-V3"
              ],
              "guideline_ids": [
                "GL-NCCN-PANC-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Kidney and liver function, albumin",
              "cadence": "Before each cycle",
              "status": "completed_today",
              "detail": "Creatinine 0.72 mg/dL, eGFR 114; ALT 26, AST 27, alkaline phosphatase 120 U/L, bilirubin 0.6 mg/dL; albumin 3.5 g/dL",
              "observation_ids": [
                "OBS-CR-V3",
                "OBS-EGFR-V3",
                "OBS-ALT-V3",
                "OBS-AST-V3",
                "OBS-ALP-V3",
                "OBS-TBIL-V3",
                "OBS-ALB-V3"
              ],
              "guideline_ids": [
                "GL-NCCN-PANC-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Magnesium",
              "cadence": "Before each cycle",
              "status": "completed_today",
              "detail": "1.9 mg/dL",
              "observation_ids": [
                "OBS-MG-V3"
              ],
              "guideline_ids": [
                "GL-NCCN-PANC-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Ferritin after intravenous iron",
              "cadence": "Four to eight weeks after the last dose",
              "status": "completed_today",
              "detail": "88 ng/mL",
              "observation_ids": [
                "OBS-FERR-V3"
              ],
              "guideline_ids": [
                "GL-NCCN-PANC-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "CA 19-9",
              "cadence": "At diagnosis after biliary drainage, every two cycles during treatment, before surgery, after surgery, then every three to six months",
              "status": "completed_today",
              "detail": "210 U/mL, from 486 at diagnosis",
              "observation_ids": [
                "OBS-CA199-V3"
              ],
              "guideline_ids": [
                "GL-NCCN-PANC-2026",
                "GL-ASCO-PANC-2016"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Interim restaging CT",
              "cadence": "Every two months during chemotherapy before surgery",
              "status": "ordered",
              "detail": "Ordered today for two weeks from now, before cycle 5",
              "guideline_ids": [
                "GL-NCCN-PANC-2026",
                "GL-ASCO-PANC-2016"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Germline multigene panel",
              "cadence": "Once, at diagnosis",
              "status": "up_to_date",
              "detail": "Negative for pathogenic variants; reviewed with the genetic counselor; no cascade testing needed",
              "guideline_ids": [
                "GL-ASCO-PANCGERM-2019",
                "GL-NCCN-PANC-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Tumor molecular profiling",
              "cadence": "At diagnosis",
              "status": "up_to_date",
              "detail": "KRAS G12D, TP53 and CDKN2A alterations; microsatellite stable; no BRCA1, BRCA2 or PALB2 variant; no NTRK, NRG1 or ALK fusion",
              "guideline_ids": [
                "GL-NCCN-PANC-2026",
                "GL-ASCO-MPC-2020"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Hepatitis B, hepatitis C and HIV screening",
              "cadence": "Before chemotherapy",
              "status": "up_to_date",
              "detail": "Negative before cycle 1; hepatitis B surface antibody negative, so vaccination after chemotherapy",
              "guideline_ids": [
                "GL-ASCO-HBV-2020"
              ]
            },
            {
              "domain": "examination",
              "measure": "Oxaliplatin neuropathy: symptoms and examination",
              "cadence": "Before each oxaliplatin dose",
              "status": "completed_today",
              "detail": "Grade 1 sensory neuropathy; full dose continues",
              "guideline_ids": [
                "GL-ASCO-CIPN-2020"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Nausea, vomiting and diarrhea control",
              "cadence": "Each cycle",
              "status": "completed_today",
              "detail": "Nausea one or two days on olanzapine; loose stools controlled with loperamide",
              "guideline_ids": [
                "GL-ASCO-ANTIEMETIC-2020",
                "GL-ASCO-DIARRHEA-2004"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Venous thromboembolism prophylaxis",
              "cadence": "During chemotherapy",
              "status": "completed_today",
              "detail": "No bleeding for eight weeks and hemoglobin 11.2 g/dL: apixaban 2.5 mg twice daily started today, with teaching on bleeding signs",
              "guideline_ids": [
                "GL-ASCO-VTE-2023",
                "GL-AVERT-2019"
              ]
            },
            {
              "domain": "survey",
              "measure": "Pain score and opioid review",
              "cadence": "Each visit",
              "status": "completed_today",
              "detail": "Pain 2 out of 10",
              "observation_ids": [
                "OBS-PAIN-V3"
              ],
              "guideline_ids": [
                "GL-ASCO-PALL-2024"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Weight, nutrition and enzyme replacement",
              "cadence": "Each visit",
              "status": "completed_today",
              "detail": "Weight 54.8 kg, 1 percent below the weight at diagnosis; stools formed on pancrelipase",
              "guideline_ids": [
                "GL-NCCN-PANC-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Glucose and home readings",
              "cadence": "Each visit and before each cycle",
              "status": "completed_today",
              "detail": "Glucose 128 mg/dL; home fasting 110 to 130",
              "observation_ids": [
                "OBS-GLU-V3"
              ],
              "guideline_ids": [
                "GL-ADA-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Dilated eye examination and urine albumin-to-creatinine ratio",
              "cadence": "At diagnosis of diabetes, then yearly",
              "status": "deferred",
              "detail": "A deviation: the dilated eye examination and urine albumin-to-creatinine ratio planned when diabetes was diagnosed were not arranged, amid staging and the start of chemotherapy. Harm is unlikely after two months of mild diabetes, but the check is a standard of care. Corrective action: both booked with the visit after surgery, when treatment visits are fewer",
              "guideline_ids": [
                "GL-ADA-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "Distress and depression screen (PHQ-9, GAD-7)",
              "cadence": "At diagnosis, at each treatment phase, and when symptoms change",
              "status": "completed_today",
              "detail": "PHQ-9 8 and GAD-7 9; worry before scans; she sees the palliative care social worker monthly",
              "observation_ids": [
                "OBS-PHQ9-V3",
                "OBS-GAD7-V3"
              ],
              "guideline_ids": [
                "GL-USPSTF-DEP-2023",
                "GL-ASCO-PALL-2024"
              ]
            }
          ],
          "follow_up": "Interim CT in two weeks. Cycles 5 and 6 every two weeks. Restaging CT and review after cycle 6. Call at once for fever of 38.0 °C or more, diarrhea not controlled by loperamide, bleeding, or yellow eyes",
          "guideline_ids": [
            "GL-NCCN-PANC-2026",
            "GL-ASCO-PANC-2016",
            "GL-ASCO-PANCGERM-2019",
            "GL-ASCO-CIPN-2020",
            "GL-ASCO-ANTIEMETIC-2020",
            "GL-ASCO-VTE-2023",
            "GL-ADA-2026",
            "GL-USPSTF-DEP-2023"
          ]
        }
      },
      {
        "id": "ENC-004",
        "display": "After six cycles: restaging CT and CA 19-9, decision for surgery, and preparation for pancreaticoduodenectomy",
        "status": "finished",
        "date": "2026-08-10",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "Review after six cycles: restaging results and the decision for surgery",
          "hpi": {
            "narrative": "Ms. Hansberry returns two weeks after her sixth and last cycle before surgery. The diarrhea after cycle 5 settled within two days with loperamide, fluids and potassium, and with irinotecan reduced for cycle 6 she had only two loose stools. The restaging CT four days ago shows the tumor smaller and less contact with the vein, with no spread, and the tumor board recommends surgery; she met the surgeon and has chosen to go ahead. The interim CT ordered before cycle 5 was never scheduled. The cold-induced tingling is fading and her fingertips feel almost normal. Pain is 1 out of 10 and she takes oxycodone once every few days. She walks 30 minutes a day to prepare for surgery. Home fasting glucose is 115 to 135 mg/dL. She has had no bleeding on apixaban. She has written most mornings this month. She has had no thoughts of self-harm.",
            "elements": [
              {
                "label": "Treatment",
                "value": "Six cycles of modified FOLFIRINOX; irinotecan reduced for cycle 6 after grade 2 diarrhea"
              },
              {
                "label": "Restaging CT",
                "value": "Mass 2.1 cm from 3.1 cm; vein contact about 150 degrees; no arterial contact; no metastases"
              },
              {
                "label": "Decision",
                "value": "Pancreaticoduodenectomy with vein resection in two weeks"
              },
              {
                "label": "Effects",
                "value": "Diarrhea resolved; neuropathy fading"
              },
              {
                "label": "Preparation",
                "value": "Walking 30 minutes daily; protein supplements"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "Energy improving; weight 54.2 kg; no fever"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "Diarrhea resolved; stools formed; no nausea; no black stools"
            },
            {
              "system": "Neurological",
              "status": "positive",
              "finding": "Fingertip tingling fading; no weakness"
            },
            {
              "system": "Hematologic and lymphatic",
              "status": "negative",
              "finding": "No bleeding or bruising on apixaban"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "No cough or breathlessness"
            },
            {
              "system": "Psychiatric",
              "status": "positive",
              "finding": "Hopeful and nervous about surgery; PHQ-9 6; no thoughts of self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; weight 54.2 kg; blood pressure 112/72, pulse 80"
            },
            {
              "system": "Eyes",
              "finding": "No icterus"
            },
            {
              "system": "Abdomen",
              "finding": "Soft, non-tender; no mass; port site clean"
            },
            {
              "system": "Neurological",
              "finding": "Light touch at the fingertips almost normal; vibration and reflexes normal"
            },
            {
              "system": "Extremities",
              "finding": "No leg swelling"
            },
            {
              "system": "Psychiatric",
              "finding": "Calm, focused, asks about recovery time for writing"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-004",
              "display": "Pancreatic head adenocarcinoma, borderline resectable, after six cycles of modified FOLFIRINOX",
              "assessment": "A partial response on CT and CA 19-9 41 U/mL from 486, with no progression, so resection is recommended by the tumor board. Fit for surgery: albumin 3.6 g/dL, weight 2 percent below the weight at diagnosis, normal kidney and liver function, INR 1.0",
              "plan": [
                "Pylorus-preserving pancreaticoduodenectomy with superior mesenteric vein resection in two weeks",
                "Stop apixaban three days before surgery; enoxaparin for four weeks after it",
                "Continue walking and protein supplements until surgery"
              ]
            },
            {
              "problem_id": "PRB-010",
              "display": "Chemotherapy-induced diarrhea",
              "assessment": "Resolved after the cycle 5 episode; only two loose stools after cycle 6 at the reduced irinotecan dose",
              "plan": [
                "Problem resolved"
              ]
            },
            {
              "problem_id": "PRB-005",
              "display": "Diabetes due to the pancreatic cancer",
              "assessment": "A1c 7.0% and glucose 124 mg/dL on no treatment. Resection of the head of the pancreas often worsens diabetes; insulin may be needed after surgery",
              "plan": [
                "Glucose monitoring in hospital, with basal insulin if needed"
              ]
            },
            {
              "problem_id": "PRB-009",
              "display": "Oxaliplatin neuropathy, grade 1",
              "assessment": "Fading two weeks after the last oxaliplatin dose",
              "plan": [
                "Review after surgery"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "imaging",
              "measure": "Restaging CT after chemotherapy before surgery",
              "cadence": "After completing therapy before surgery",
              "status": "up_to_date",
              "detail": "Four days ago: partial response; vein contact about 150 degrees; no arterial contact; no metastases",
              "guideline_ids": [
                "GL-NCCN-PANC-2026",
                "GL-ASCO-PANC-2016"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Interim restaging CT",
              "cadence": "Every two months during chemotherapy before surgery",
              "status": "deferred",
              "detail": "A deviation: the interim CT ordered at cycle 4 was never scheduled. No harm resulted: CA 19-9 kept falling and today's CT shows a response without progression. Corrective action: the nurse navigator now tracks every imaging order to a booked date",
              "guideline_ids": [
                "GL-NCCN-PANC-2026",
                "GL-ASCO-PANC-2016"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "CA 19-9",
              "cadence": "At diagnosis after biliary drainage, every two cycles during treatment, before surgery, after surgery, then every three to six months",
              "status": "completed_today",
              "detail": "41 U/mL, from 210 at cycle 4 and 486 at diagnosis",
              "observation_ids": [
                "OBS-CA199-V4"
              ],
              "guideline_ids": [
                "GL-NCCN-PANC-2026",
                "GL-ASCO-PANC-2016"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Blood count with neutrophils and platelets",
              "cadence": "Before surgery",
              "status": "completed_today",
              "detail": "Hemoglobin 10.9 g/dL, white cells 7.8, neutrophils 4.9, platelets 176",
              "observation_ids": [
                "OBS-HGB-V4",
                "OBS-WBC-V4",
                "OBS-ANC-V4",
                "OBS-PLT-V4"
              ],
              "guideline_ids": [
                "GL-NCCN-PANC-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Kidney and liver function, electrolytes and albumin before surgery",
              "cadence": "Within 30 days before surgery",
              "status": "completed_today",
              "detail": "Sodium 138, potassium 4.1 mmol/L; creatinine 0.76 mg/dL, eGFR 107; ALT 24, AST 26, alkaline phosphatase 98 U/L, bilirubin 0.5 mg/dL; albumin 3.6 g/dL",
              "observation_ids": [
                "OBS-NA-V4",
                "OBS-K-V4",
                "OBS-CR-V4",
                "OBS-EGFR-V4",
                "OBS-ALT-V4",
                "OBS-AST-V4",
                "OBS-ALP-V4",
                "OBS-TBIL-V4",
                "OBS-ALB-V4"
              ],
              "guideline_ids": [
                "GL-NCCN-PANC-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "INR before surgery",
              "cadence": "Before surgery",
              "status": "completed_today",
              "detail": "1.0",
              "observation_ids": [
                "OBS-INR-V4"
              ],
              "guideline_ids": [
                "GL-NCCN-PANC-2026"
              ]
            },
            {
              "domain": "referral",
              "measure": "Pancreatic tumor board and surgical oncology",
              "cadence": "After restaging",
              "status": "up_to_date",
              "detail": "Tumor board three days ago and surgical consultation: resection recommended and accepted",
              "guideline_ids": [
                "GL-NCCN-PANC-2026",
                "GL-ASCO-PANC-2016"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Anticoagulation around surgery",
              "cadence": "Before and after surgery",
              "status": "completed_today",
              "detail": "Apixaban stopped three days before surgery; enoxaparin 40 mg daily for four weeks after it",
              "guideline_ids": [
                "GL-ASCO-VTE-2023",
                "GL-AVERT-2019"
              ]
            },
            {
              "domain": "examination",
              "measure": "Oxaliplatin neuropathy: symptoms and examination",
              "cadence": "At each visit after oxaliplatin",
              "status": "completed_today",
              "detail": "Grade 1 and fading",
              "guideline_ids": [
                "GL-ASCO-CIPN-2020"
              ]
            },
            {
              "domain": "survey",
              "measure": "Pain score and opioid review",
              "cadence": "Each visit",
              "status": "completed_today",
              "detail": "Pain 1 out of 10; oxycodone once every few days",
              "observation_ids": [
                "OBS-PAIN-V4"
              ],
              "guideline_ids": [
                "GL-ASCO-PALL-2024"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Weight, nutrition and enzyme replacement",
              "cadence": "Each visit",
              "status": "completed_today",
              "detail": "Weight 54.2 kg, 2 percent below the weight at diagnosis; protein supplements and walking to prepare for surgery",
              "guideline_ids": [
                "GL-NCCN-PANC-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Glucose and home readings",
              "cadence": "Each visit and before each cycle",
              "status": "completed_today",
              "detail": "Glucose 124 mg/dL",
              "observation_ids": [
                "OBS-GLU-V4"
              ],
              "guideline_ids": [
                "GL-ADA-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "A1c",
              "cadence": "Every three months while treatment changes",
              "status": "completed_today",
              "detail": "7.0%, from 6.6% at the first visit",
              "observation_ids": [
                "OBS-A1C-V4"
              ],
              "guideline_ids": [
                "GL-ADA-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Dilated eye examination and urine albumin-to-creatinine ratio",
              "cadence": "At diagnosis of diabetes, then yearly",
              "status": "deferred",
              "detail": "Still outstanding (see the deviation at cycle 4); booked with the visit after surgery",
              "guideline_ids": [
                "GL-ADA-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "Distress and depression screen (PHQ-9, GAD-7)",
              "cadence": "At diagnosis, at each treatment phase, and when symptoms change",
              "status": "completed_today",
              "detail": "PHQ-9 6",
              "observation_ids": [
                "OBS-PHQ9-V4"
              ],
              "guideline_ids": [
                "GL-USPSTF-DEP-2023",
                "GL-ASCO-PALL-2024"
              ]
            }
          ],
          "follow_up": "Surgery in two weeks. Primary care review about six weeks after surgery with the pathology. Call for fever, bleeding, or leg swelling before then",
          "guideline_ids": [
            "GL-NCCN-PANC-2026",
            "GL-ASCO-PANC-2016",
            "GL-ASCO-VTE-2023",
            "GL-ASCO-CIPN-2020",
            "GL-ADA-2026",
            "GL-CMID-2026",
            "GL-USPSTF-DEP-2023"
          ]
        }
      },
      {
        "id": "ENC-005",
        "display": "Six weeks after pancreaticoduodenectomy: pathology, diabetes and enzyme replacement after surgery, and the plan for chemotherapy after surgery",
        "status": "finished",
        "date": "2026-10-05",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "Review six weeks after pancreaticoduodenectomy: pathology, diabetes, digestion, and the plan for chemotherapy after surgery",
          "hpi": {
            "narrative": "Ms. Hansberry returns six weeks after a pylorus-preserving pancreaticoduodenectomy with resection of a segment of the superior mesenteric vein. She was in hospital nine days; her stomach was slow to empty for the first week and then recovered. Insulin glargine was started four days after surgery when her glucose rose, and her home fasting readings are now 140 to 170 mg/dL on 8 units. She finished four weeks of enoxaparin two weeks ago. Since surgery her stools have been loose and pale after larger meals despite pancrelipase. She has lost 2.4 kg since surgery. Pain is 2 out of 10 at the wound and she rarely needs oxycodone. She is writing again for an hour each morning. Fingertip tingling is barely there. She saw Dr. Adeyemi-Rourke last week, who recommends chemotherapy after surgery starting next week. She has had no thoughts of self-harm.",
            "elements": [
              {
                "label": "Operation",
                "value": "Pylorus-preserving pancreaticoduodenectomy with vein resection; nine days in hospital; delayed gastric emptying resolved"
              },
              {
                "label": "Pathology",
                "value": "ypT2N1: 2.3 cm residual adenocarcinoma, 2 of 18 nodes, perineural invasion; all margins clear (R0); partial treatment response"
              },
              {
                "label": "Diabetes",
                "value": "Insulin glargine 8 units since day 4; fasting 140 to 170 mg/dL"
              },
              {
                "label": "Digestion",
                "value": "Loose, pale stools after larger meals; weight down 2.4 kg since surgery"
              },
              {
                "label": "Plan proposed",
                "value": "Six cycles of fluorouracil, leucovorin and irinotecan, without oxaliplatin, starting next week"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Tired in the afternoons; weight 51.8 kg; no fever"
            },
            {
              "system": "Gastrointestinal",
              "status": "positive",
              "finding": "Loose, pale stools after larger meals; eating five small meals; no vomiting"
            },
            {
              "system": "Endocrine",
              "status": "positive",
              "finding": "Fasting glucose 140 to 170 mg/dL; no low readings"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "Fingertip tingling barely present"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No leg swelling or calf pain"
            },
            {
              "system": "Psychiatric",
              "status": "positive",
              "finding": "Relieved about the margins, worried about the lymph nodes; PHQ-9 7, GAD-7 6; no thoughts of self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Thin, well; weight 51.8 kg; blood pressure 106/68, pulse 86"
            },
            {
              "system": "Abdomen",
              "finding": "Healed upper midline and right subcostal incision without hernia or redness; soft; mildly tender at the wound"
            },
            {
              "system": "Eyes",
              "finding": "No icterus"
            },
            {
              "system": "Feet",
              "finding": "Monofilament sensation and pulses normal; no lesions"
            },
            {
              "system": "Extremities",
              "finding": "No leg swelling"
            },
            {
              "system": "Psychiatric",
              "finding": "Engaged; planning her writing around the treatment days"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-004",
              "display": "Pancreatic head adenocarcinoma, ypT2N1, R0 resection after modified FOLFIRINOX",
              "assessment": "A complete resection with clear margins after a partial response. Two lymph nodes were involved, so the risk of return is real. CA 19-9 is now normal at 18 U/mL. Dr. Adeyemi-Rourke recommends chemotherapy after surgery to complete about six months of treatment in all: six more cycles of fluorouracil, leucovorin and irinotecan every two weeks, keeping the reduced irinotecan dose and leaving out oxaliplatin so that the neuropathy does not return in her hands. She agrees. Counts, kidney and liver function allow it",
              "plan": [
                "Cycle 1 after surgery in one week, with pegfilgrastim on day 3",
                "Apixaban 2.5 mg twice daily again from the first cycle",
                "After chemotherapy: history, examination, CA 19-9 and CT every three to six months for two years"
              ]
            },
            {
              "problem_id": "PRB-011",
              "display": "After pancreaticoduodenectomy",
              "assessment": "Loose, pale stools after larger meals mean the enzyme dose is now too low after removal of the head of the pancreas; weight is 6.5 percent below the weight at diagnosis",
              "plan": [
                "Pancrelipase increased to three capsules (108,000 lipase units) with meals and two with snacks",
                "Dietitian review this week",
                "Vitamin D level at the next blood test"
              ]
            },
            {
              "problem_id": "PRB-005",
              "display": "Diabetes due to pancreatic disease, now on insulin",
              "assessment": "Glucose 156 mg/dL today and fasting readings 140 to 170 on 8 units of glargine; no lows. Urine albumin-to-creatinine ratio 12 mg/g, normal",
              "plan": [
                "Insulin glargine increased to 10 units at night",
                "Hypoglycemia teaching repeated, with glucose tablets at her desk",
                "Dilated eye examination booked for next week",
                "A1c in December"
              ]
            },
            {
              "problem_id": "PRB-008",
              "display": "Obstruction of the bile duct",
              "assessment": "Relieved: the stent was removed and the bile duct reconnected at surgery; bilirubin 0.5 mg/dL",
              "plan": [
                "Problem resolved"
              ]
            },
            {
              "problem_id": "PRB-009",
              "display": "Oxaliplatin neuropathy, grade 1",
              "assessment": "Almost resolved; no oxaliplatin is planned",
              "plan": [
                "Review at each visit"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "laboratory",
              "measure": "Surgical pathology",
              "cadence": "After resection",
              "status": "up_to_date",
              "detail": "ypT2N1 (2 of 18 nodes), R0, perineural invasion, CAP tumor regression score 2",
              "guideline_ids": [
                "GL-NCCN-PANC-2026",
                "GL-ASCO-PANC-2016"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "CA 19-9",
              "cadence": "At diagnosis after biliary drainage, every two cycles during treatment, before surgery, after surgery, then every three to six months",
              "status": "completed_today",
              "detail": "18 U/mL, normal",
              "observation_ids": [
                "OBS-CA199-V5"
              ],
              "guideline_ids": [
                "GL-NCCN-PANC-2026",
                "GL-ASCO-PANC-2016"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Blood count with neutrophils and platelets",
              "cadence": "Before chemotherapy after surgery",
              "status": "completed_today",
              "detail": "Hemoglobin 10.6 g/dL, white cells 8.2, neutrophils 5.1, platelets 302",
              "observation_ids": [
                "OBS-HGB-V5",
                "OBS-WBC-V5",
                "OBS-ANC-V5",
                "OBS-PLT-V5"
              ],
              "guideline_ids": [
                "GL-NCCN-PANC-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Kidney and liver function, electrolytes and albumin",
              "cadence": "Before chemotherapy after surgery",
              "status": "completed_today",
              "detail": "Sodium 137, potassium 4.3 mmol/L; creatinine 0.71 mg/dL, eGFR 116; ALT 22, AST 24, alkaline phosphatase 110 U/L, bilirubin 0.5 mg/dL; albumin 3.4 g/dL",
              "observation_ids": [
                "OBS-NA-V5",
                "OBS-K-V5",
                "OBS-CR-V5",
                "OBS-EGFR-V5",
                "OBS-ALT-V5",
                "OBS-AST-V5",
                "OBS-ALP-V5",
                "OBS-TBIL-V5",
                "OBS-ALB-V5"
              ],
              "guideline_ids": [
                "GL-NCCN-PANC-2026"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Baseline CT after surgery",
              "cadence": "Before chemotherapy after surgery or within three months of surgery",
              "status": "due",
              "detail": "Ordered with the oncology team for before the third cycle after surgery; the CT before surgery showed no spread",
              "guideline_ids": [
                "GL-NCCN-PANC-2026",
                "GL-ASCO-PANC-2016"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Venous thromboembolism prophylaxis",
              "cadence": "After surgery and during chemotherapy",
              "status": "completed_today",
              "detail": "Enoxaparin for four weeks after surgery completed; apixaban 2.5 mg twice daily to restart with chemotherapy",
              "guideline_ids": [
                "GL-ASCO-VTE-2023",
                "GL-AVERT-2019"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Weight, nutrition and enzyme replacement",
              "cadence": "Each visit",
              "status": "completed_today",
              "detail": "Weight 51.8 kg, 6.5 percent below the weight at diagnosis; pancrelipase increased; dietitian this week",
              "guideline_ids": [
                "GL-NCCN-PANC-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Glucose and home readings",
              "cadence": "Each visit and before each cycle",
              "status": "completed_today",
              "detail": "Glucose 156 mg/dL; home fasting 140 to 170 on 8 units of glargine",
              "observation_ids": [
                "OBS-GLU-V5"
              ],
              "guideline_ids": [
                "GL-ADA-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "A1c",
              "cadence": "Every three months while treatment changes",
              "status": "up_to_date",
              "detail": "7.0% eight weeks ago; next in December, three months after that one",
              "guideline_ids": [
                "GL-ADA-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Dilated eye examination and urine albumin-to-creatinine ratio",
              "cadence": "At diagnosis of diabetes, then yearly",
              "status": "completed_today",
              "detail": "Urine albumin-to-creatinine ratio 12 mg/g today, normal, closing part of the deviation recorded at cycle 4. The dilated eye examination is booked for next week",
              "observation_ids": [
                "OBS-UACR-V5"
              ],
              "guideline_ids": [
                "GL-ADA-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Foot examination",
              "cadence": "At diagnosis of diabetes, then yearly",
              "status": "completed_today",
              "detail": "Normal sensation and pulses",
              "guideline_ids": [
                "GL-ADA-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Oxaliplatin neuropathy: symptoms and examination",
              "cadence": "At each visit after oxaliplatin",
              "status": "completed_today",
              "detail": "Almost resolved",
              "guideline_ids": [
                "GL-ASCO-CIPN-2020"
              ]
            },
            {
              "domain": "survey",
              "measure": "Pain score and opioid review",
              "cadence": "Each visit",
              "status": "completed_today",
              "detail": "Pain 2 out of 10 at the wound",
              "observation_ids": [
                "OBS-PAIN-V5"
              ],
              "guideline_ids": [
                "GL-ASCO-PALL-2024"
              ]
            },
            {
              "domain": "survey",
              "measure": "Distress and depression screen (PHQ-9, GAD-7)",
              "cadence": "At diagnosis, at each treatment phase, and when symptoms change",
              "status": "completed_today",
              "detail": "PHQ-9 7 and GAD-7 6",
              "observation_ids": [
                "OBS-PHQ9-V5",
                "OBS-GAD7-V5"
              ],
              "guideline_ids": [
                "GL-USPSTF-DEP-2023",
                "GL-ASCO-PALL-2024"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Serious illness conversation and advance care planning",
              "cadence": "At diagnosis and at each change in treatment",
              "status": "completed_today",
              "detail": "Reviewed with palliative care last week; to be recorded formally at the preventive visit",
              "guideline_ids": [
                "GL-ASCO-PALL-2024"
              ]
            }
          ],
          "follow_up": "Chemotherapy after surgery from next week. Dietitian and eye examination this week and next. Preventive visit in about two weeks. Call for fever of 38.0 °C or more, yellow eyes, low glucose readings, or worsening diarrhea",
          "guideline_ids": [
            "GL-NCCN-PANC-2026",
            "GL-ASCO-PANC-2016",
            "GL-ASCO-PANC-2019",
            "GL-ASCO-VTE-2023",
            "GL-ADA-2026",
            "GL-CMID-2026",
            "GL-ASCO-PALL-2024",
            "GL-USPSTF-DEP-2023"
          ]
        }
      },
      {
        "id": "ENC-006",
        "display": "Same-day sick visit for diarrhea during chemotherapy",
        "status": "finished",
        "date": "2026-07-16",
        "visit_type": "sick",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "185345009",
          "display": "Encounter for symptom",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "Watery diarrhea since yesterday, three days after chemotherapy",
          "billing_note": "Problem-oriented office visit, established patient, with intravenous fluids in the infusion center",
          "hpi": {
            "narrative": "Ms. Hansberry called the oncology line on day 4 of her fifth cycle of modified FOLFIRINOX and was seen the same day. The pump was disconnected two days ago and pegfilgrastim given. Since yesterday afternoon she has had six watery stools, two of them overnight, and mild cramping. She took loperamide 4 mg at the first loose stool and 2 mg after each one since, eight tablets in all. Her stools are not pale or greasy as they were before pancrelipase, and there is no blood or black stool. She has had no fever (highest 37.2 °C at home), vomiting, or antibiotics, and no one around her is ill. She feels light-headed when she stands and has been drinking less than usual because of the cramps. She is eating little. Her blood glucose readings at home have been 110 to 150 mg/dL. She was writing every morning last week and wants to be back at her desk by the weekend. She has had no thoughts of self-harm.",
            "elements": [
              {
                "label": "Onset",
                "value": "Yesterday afternoon, on day 3 of cycle 5"
              },
              {
                "label": "Severity",
                "value": "Six watery stools a day above her usual; cramping; no blood"
              },
              {
                "label": "Context",
                "value": "Irinotecan late diarrhea is expected two to ten days after a dose; pegfilgrastim given two days ago"
              },
              {
                "label": "Treatment so far",
                "value": "Loperamide 4 mg, then 2 mg after each loose stool: eight tablets"
              },
              {
                "label": "Associated signs and symptoms",
                "value": "Light-headed on standing; no fever, vomiting, blood, or antibiotic use"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Tired and light-headed on standing; no fever or chills"
            },
            {
              "system": "Gastrointestinal",
              "status": "positive",
              "finding": "Watery diarrhea and cramping; no blood, black stool, or vomiting"
            },
            {
              "system": "Genitourinary",
              "status": "positive",
              "finding": "Passing less urine than usual"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No chest pain or leg swelling"
            },
            {
              "system": "Endocrine",
              "status": "negative",
              "finding": "Home glucose 110 to 150 mg/dL; no low readings"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Frustrated at losing writing days; no thoughts of self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Tired but alert; weight 53.6 kg, down 1.2 kg from the weight at cycle 4; temperature 37.1 °C"
            },
            {
              "system": "Vital signs",
              "finding": "Lying 104/66 with pulse 96; standing 96/60 with pulse 112 and light-headedness: orthostatic"
            },
            {
              "system": "Head, eyes, ears, nose, and throat",
              "finding": "Dry mouth; no mouth sores"
            },
            {
              "system": "Abdomen",
              "finding": "Soft, mildly tender in the lower abdomen without guarding; active bowel sounds; no distension"
            },
            {
              "system": "Skin",
              "finding": "Port site clean; no jaundice"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-010",
              "display": "Chemotherapy-induced diarrhea, grade 2, from irinotecan",
              "assessment": "Late irinotecan diarrhea, grade 2, with mild dehydration (orthostatic, creatinine 0.94 from 0.72) and losses of potassium (3.2) and magnesium (1.6). No fever, the neutrophil count is 4.1, and she has had no antibiotics, so this is uncomplicated; a stool test for Clostridioides difficile toxin was sent as a precaution and was negative later today. Not steatorrhea: the stools are watery, not pale or greasy, and she is taking pancrelipase with every meal",
              "plan": [
                "One liter of normal saline in the infusion center today, with magnesium sulfate 2 g intravenously",
                "Potassium chloride 40 mEq by mouth today, then 20 mEq daily for three days",
                "Loperamide 4 mg now, then 2 mg every two hours (4 mg every four hours at night) until 12 hours pass without a loose stool; oral rehydration solution",
                "Call at once for fever of 38.0 °C or more, blood in the stool, fainting, or diarrhea lasting beyond 24 hours on this regimen; that would need admission and octreotide",
                "Irinotecan reduced by one dose level (to 120 mg/m2) for cycle 6, as Dr. Adeyemi-Rourke's team agreed"
              ]
            },
            {
              "problem_id": "PRB-005",
              "display": "Diabetes due to the pancreatic cancer",
              "assessment": "Glucose 118 mg/dL; eating little, so no change",
              "plan": [
                "Continue home glucose checks"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Pancreatic head adenocarcinoma, borderline resectable, on modified FOLFIRINOX",
              "assessment": "Cycle 5 of six given on schedule; CA 19-9 falling at cycle 4",
              "plan": [
                "Cycle 6 in 11 days if the diarrhea has settled and the potassium is normal"
              ]
            }
          ],
          "follow_up": "Phone call tomorrow morning and blood test (potassium, magnesium, creatinine) in two days. Cycle 6 as booked if recovered",
          "guideline_ids": [
            "GL-ASCO-DIARRHEA-2004",
            "GL-NCCN-PANC-2026"
          ]
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic unscheduled sick visit; the illness is a synthetic treatment effect, not a historical claim.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "ENC-007",
        "display": "Periodic adult preventive visit during chemotherapy after surgery",
        "status": "finished",
        "date": "2026-10-21",
        "visit_type": "preventive_adult",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "86013001",
          "display": "Periodic reevaluation and management of healthy individual",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "Periodic adult preventive visit, on day 10 of the first cycle of chemotherapy after surgery",
          "billing_note": "CPT 99395 (periodic preventive medicine, established patient, age 18 to 39) with CPT 99497 (advance care planning) on the same day",
          "health_risk_assessment_method": "Completed by the patient on a tablet in the waiting room and reviewed with her by Dr. Marchetti-Fields",
          "hpi": {
            "narrative": "Ms. Hansberry, now 33, comes for her yearly preventive visit on day 10 of the first cycle of fluorouracil, leucovorin and irinotecan after her pancreaticoduodenectomy. The cycle went well: one day of nausea settled with olanzapine, two loose stools on day 4 controlled with loperamide, and no fever. She takes pancrelipase three capsules with meals and two with snacks, and her stools are formed. Insulin glargine is 10 units at night; fasting readings are 110 to 140 mg/dL with no low readings. She takes apixaban twice a day without bleeding. The tingling in her fingers in the cold is fading now that oxaliplatin has stopped. She writes most mornings and has finished a draft of the new play's second act. Her PHQ-9 today is 5.",
            "elements": [
              {
                "label": "Visit",
                "value": "Periodic adult preventive visit, age 33"
              },
              {
                "label": "Active conditions",
                "value": "Pancreatic adenocarcinoma after six cycles of modified FOLFIRINOX and pancreaticoduodenectomy (R0); on chemotherapy after surgery; diabetes due to pancreatic disease on insulin; exocrine pancreatic insufficiency on pancrelipase"
              },
              {
                "label": "Medicines",
                "value": "Fluorouracil, leucovorin and irinotecan every two weeks; pegfilgrastim; apixaban 2.5 mg twice daily; insulin glargine 10 units; pancrelipase; pantoprazole; olanzapine, ondansetron and loperamide as needed; oxycodone rarely"
              },
              {
                "label": "Mood",
                "value": "PHQ-9 5"
              }
            ]
          },
          "health_risk_assessment": [
            {
              "domain": "Self-rated health",
              "finding": "Fair, and better than before surgery"
            },
            {
              "domain": "Psychosocial",
              "finding": "Close friends and fellow writers visit and drive her to treatment; worry about the cancer returning; writing gives her purpose"
            },
            {
              "domain": "Tobacco",
              "finding": "Never smoked"
            },
            {
              "domain": "Alcohol and drugs",
              "finding": "No alcohol since diagnosis; no drugs"
            },
            {
              "domain": "Physical activity",
              "finding": "Walks 20 minutes by the river most days"
            },
            {
              "domain": "Nutrition",
              "finding": "Five small meals a day with pancrelipase; weight steady since surgery; follows the dietitian's plan"
            },
            {
              "domain": "Sleep",
              "finding": "Seven hours, broken on the nights after chemotherapy"
            },
            {
              "domain": "Sexual and reproductive health",
              "finding": "Not sexually active now; would use condoms and talk to the clinic first; does not want a pregnancy during or soon after treatment"
            },
            {
              "domain": "Safety at home",
              "finding": "Feels safe; no one hurts, threatens, or controls her; no firearm in the home"
            },
            {
              "domain": "Road safety",
              "finding": "Wears a seat belt; friends drive her on treatment days"
            },
            {
              "domain": "Activities of daily living",
              "finding": "Independent"
            }
          ],
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Tired for two days after each cycle; no fever, night sweats or weight loss since surgery"
            },
            {
              "system": "Eyes",
              "status": "negative",
              "finding": "No vision change; dilated eye examination last week normal"
            },
            {
              "system": "Ears, nose, mouth, and throat",
              "status": "negative",
              "finding": "No mouth sores"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No chest pain or leg swelling"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "No cough or breathlessness"
            },
            {
              "system": "Gastrointestinal",
              "status": "positive",
              "finding": "Nausea for one day and two loose stools after the cycle; stools otherwise formed; no abdominal pain or yellow eyes"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "No urinary symptoms; periods irregular since chemotherapy"
            },
            {
              "system": "Breast",
              "status": "negative",
              "finding": "No lump or nipple discharge"
            },
            {
              "system": "Musculoskeletal",
              "status": "negative",
              "finding": "No joint or bone pain"
            },
            {
              "system": "Integumentary",
              "status": "negative",
              "finding": "Hair thinning; incision healed"
            },
            {
              "system": "Neurological",
              "status": "positive",
              "finding": "Tingling in the fingertips in the cold, fading"
            },
            {
              "system": "Endocrine",
              "status": "negative",
              "finding": "No low glucose readings"
            },
            {
              "system": "Hematologic and lymphatic",
              "status": "negative",
              "finding": "No bruising or bleeding on apixaban"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood fair; PHQ-9 5; no thoughts of self-harm"
            }
          ],
          "exam": [
            {
              "system": "Constitutional",
              "finding": "Well; weight 52.4 kg, BMI 19.7; blood pressure 106/66"
            },
            {
              "system": "Head, eyes, ears, nose, and throat",
              "finding": "No mouth sores; no scleral icterus"
            },
            {
              "system": "Neck",
              "finding": "No lymph nodes; thyroid normal"
            },
            {
              "system": "Breasts",
              "finding": "Examined with her agreement and a chaperone: no mass, skin change or nipple discharge; no axillary nodes"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm; no murmur; no leg swelling"
            },
            {
              "system": "Respiratory",
              "finding": "Clear to auscultation bilaterally"
            },
            {
              "system": "Abdomen",
              "finding": "Healed upper midline and right subcostal incision; soft, non-tender; no mass, no fluid"
            },
            {
              "system": "Skin",
              "finding": "Port site clean; no rash or bruising"
            },
            {
              "system": "Feet",
              "finding": "Monofilament sensation normal; pulses present; no lesions"
            },
            {
              "system": "Neurological",
              "finding": "Light touch slightly reduced at the fingertips; vibration and reflexes normal; steady gait"
            },
            {
              "system": "Psychiatric",
              "finding": "Thoughtful, wry and engaged"
            }
          ],
          "assessment_plan": [
            {
              "display": "Periodic adult preventive visit completed",
              "assessment": "Health risk assessment reviewed and the prevention plan updated for a woman of 33 in treatment for pancreatic cancer. Cervical screening is due (last test four years ago, normal); she prefers to have it after chemotherapy ends, which is reasonable. Influenza and COVID-19 vaccines given today, between cycles; no live vaccines during chemotherapy. Hepatitis B surface antibody was negative before chemotherapy, so hepatitis B vaccination is due after chemotherapy, when the response will be better. Contraception was discussed again: estrogen-containing methods are not advised because of her clot risk; condoms for now, and a copper or levonorgestrel IUD if she wants one later",
              "plan": [
                "Influenza and COVID-19 vaccines given today",
                "Cervical screening (HPV test) after chemotherapy ends",
                "Hepatitis B vaccine series after chemotherapy",
                "Lipid panel with the next routine blood tests",
                "Next preventive visit in one year"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Pancreatic head adenocarcinoma after neoadjuvant chemotherapy and pancreaticoduodenectomy (ypT2N1, R0), on chemotherapy after surgery",
              "assessment": "First cycle of fluorouracil, leucovorin and irinotecan tolerated well. Surveillance after treatment will be with history, examination, CA 19-9 and CT every three to six months for two years",
              "plan": [
                "Cycle 2 in five days",
                "Continue apixaban 2.5 mg twice daily during chemotherapy"
              ]
            },
            {
              "problem_id": "PRB-005",
              "display": "Diabetes due to pancreatic disease, on insulin",
              "assessment": "Fasting glucose 110 to 140 mg/dL with no low readings; the dilated eye examination last week was normal",
              "plan": [
                "Continue insulin glargine 10 units at night",
                "A1c in December"
              ]
            }
          ],
          "prevention_plan": [
            {
              "service": "Blood pressure screening",
              "status": "completed_today",
              "detail": "106/66 mmHg",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Depression screening",
              "status": "completed_today",
              "detail": "PHQ-9 score 5; item 9 scored 0",
              "guideline_ids": [
                "GL-USPSTF-DEP-2023"
              ]
            },
            {
              "service": "Unhealthy alcohol use screening",
              "status": "completed_today",
              "detail": "No alcohol since diagnosis",
              "guideline_ids": [
                "GL-USPSTF-ALC-2018"
              ]
            },
            {
              "service": "Tobacco use",
              "status": "completed_today",
              "detail": "Never smoked",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Intimate partner violence screening",
              "status": "completed_today",
              "detail": "Negative; she feels safe",
              "guideline_ids": [
                "GL-USPSTF-IPV-2018"
              ]
            },
            {
              "service": "Cervical cancer screening",
              "status": "due",
              "detail": "Due (last test four years ago, normal); HPV test planned after chemotherapy ends, at her choice",
              "guideline_ids": [
                "GL-USPSTF-CERV-2018"
              ]
            },
            {
              "service": "Breast cancer screening",
              "status": "not_indicated",
              "detail": "Screening mammography starts at 40; no family history of breast or ovarian cancer; germline panel negative",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Colorectal cancer screening",
              "status": "not_indicated",
              "detail": "Starts at 45; germline panel negative for Lynch syndrome genes",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "HIV, hepatitis B and hepatitis C screening",
              "status": "up_to_date",
              "detail": "All negative before chemotherapy; hepatitis B surface antibody negative",
              "guideline_ids": [
                "GL-USPSTF-AB",
                "GL-ASCO-HBV-2020"
              ]
            },
            {
              "service": "Diabetes care: A1c, eye and foot examination, urine albumin",
              "status": "up_to_date",
              "detail": "A1c 7.0% in August; dilated eye examination last week normal; foot examination today normal; urine albumin-to-creatinine ratio normal at the visit after surgery",
              "guideline_ids": [
                "GL-ADA-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "service": "Lipid screening",
              "status": "due",
              "detail": "Recommended for adults with diabetes; with the next blood tests",
              "guideline_ids": [
                "GL-ADA-2026"
              ]
            },
            {
              "service": "Influenza vaccine",
              "status": "completed_today",
              "detail": "Inactivated vaccine given between cycles",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "COVID-19 vaccine",
              "status": "completed_today",
              "detail": "This season's mRNA vaccine given",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Pneumococcal vaccine",
              "status": "up_to_date",
              "detail": "PCV20 before chemotherapy",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Recombinant zoster vaccine",
              "status": "up_to_date",
              "detail": "Two doses, before and during chemotherapy, for an adult on immunosuppressive treatment",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Hepatitis B vaccine",
              "status": "due",
              "detail": "Surface antibody negative; series after chemotherapy ends",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Tetanus, diphtheria, and pertussis",
              "status": "up_to_date",
              "detail": "Tdap four years ago",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Live vaccines (MMR, varicella)",
              "status": "not_indicated",
              "detail": "Immune from childhood doses; live vaccines are avoided during chemotherapy",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Contraception counseling",
              "status": "completed_today",
              "detail": "No estrogen because of clot risk; condoms for now; IUD offered for later",
              "guideline_ids": [
                "GL-ASCO-FERT-2018"
              ]
            },
            {
              "service": "Dental examination",
              "status": "due",
              "detail": "Cleaning between cycles when counts are recovered",
              "guideline_ids": [
                "GL-PREV-2026"
              ]
            }
          ],
          "advance_care_planning": "Voluntary advance care planning discussion of about 30 minutes, with her consent, building on her conversations with the palliative care team. She named a health care agent, recorded in the confidential part of the chart and not named here, and completed a health care proxy form. She said that she wants to be told everything about her illness directly and in plain words, never through someone else; that she wants all treatment that has a real chance of controlling the cancer, as long as she can think clearly and write; and that if the cancer returns and can no longer be controlled, she would want care focused on comfort and on time at her desk and with her friends, at home if possible, rather than intensive care. She asked that her pain be treated fully even if it makes her sleepier near the end. To be revisited at each change in her health and at least yearly.",
          "follow_up": "Cycle 2 in five days. Cervical screening and the hepatitis B vaccine series after chemotherapy. Next preventive visit in one year",
          "guideline_ids": [
            "GL-PREV-2026",
            "GL-USPSTF-AB",
            "GL-CDC-IMZ-2026",
            "GL-USPSTF-CERV-2018",
            "GL-ADA-2026",
            "GL-ASCO-PALL-2024"
          ]
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic periodic preventive visit.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      }
    ],
    "vital_sign_sets": [
      {
        "id": "VSET-001",
        "date": "2026-04-20",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 163,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 56.2,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 21.2,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 104,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 66,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 102,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.8,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 99,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs at presentation: a fast pulse with anemia; no measurement from her life is used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "VSET-002",
        "date": "2026-05-04",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 163,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 55.4,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 20.9,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 108,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 68,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 92,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.7,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 99,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from her life is used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "VSET-003",
        "date": "2026-06-29",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 163,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 54.8,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 20.6,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 110,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 70,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 84,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 99,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from her life is used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "VSET-004",
        "date": "2026-08-10",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 163,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 54.2,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 20.4,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 112,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 72,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 80,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 99,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from her life is used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "VSET-005",
        "date": "2026-10-05",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 163,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 51.8,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 19.5,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 106,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 68,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 86,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.7,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 99,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from her life is used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "VSET-006",
        "date": "2026-07-16",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 163,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 53.6,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 20.2,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 98,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 62,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 104,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 37.1,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 99,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs at the sick visit: a fast pulse and lower blood pressure from fluid loss; no fever. Lying 104/66 with pulse 96, standing 96/60 with pulse 112.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "VSET-007",
        "date": "2026-10-21",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 163,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 52.4,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 19.7,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 106,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 66,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 84,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 99,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs at the preventive visit.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      }
    ],
    "social_history": [
      {
        "id": "SOC-001",
        "display": "Playwright and essayist; writes at home most days and is finishing a new play, with readings and rehearsals planned; speaks at civil rights events",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic modern work history anchored to her documented career as a playwright and activist.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "SOC-002",
        "display": "Lives alone in a small town on the Hudson River north of New York City and keeps a room in the city for theater work; separated, with no children; a close circle of friends and fellow writers; family in Chicago. No relative or friend is named or given a role in her care",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic household anchored to her documented move to Croton-on-Hudson; no real person is given a role.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "SOC-003",
        "display": "Grew up in Chicago in a family that challenged housing segregation in court; she is alert to being dismissed in health care and wants to be told the truth plainly",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0002"
          ],
          "synthetic_reason": "Synthetic preference anchored to her documented childhood.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "SOC-004",
        "display": "Never smoker; alcohol a glass of wine some evenings; no drug use",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic substance history for the modern episode; her real use was not researched and is not used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "SOC-005",
        "display": "Not pregnant and not trying to conceive; periods regular; uses condoms when sexually active",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic reproductive history; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      }
    ],
    "functional_status": [
      {
        "id": "FUNC-001",
        "display": "Independent; working full days until the last two weeks, when tiredness and pain cut her writing to the mornings (ECOG performance status 1)",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic functional status at presentation.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      }
    ],
    "mental_status": [
      {
        "id": "MSE-001",
        "display": "Alert, articulate and exact; worried and tired; PHQ-2 negative; no thoughts of self-harm",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic mental-status finding; not a claim about her real mental state.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      }
    ],
    "consultation": {
      "referral": {
        "question": "Suspected pancreatic or duodenal cancer in a 32-year-old playwright with two months of epigastric pain boring through to the back, a 5 kg weight loss, black stools with iron deficiency anemia (hemoglobin 9.1 g/dL, ferritin 6 ng/mL), new diabetes (A1c 6.6%) and a cholestatic liver pattern. Upper endoscopy and pancreas-protocol CT are booked this week. Please see her within two weeks to review the results with her and plan treatment if cancer is found",
        "urgency": "Urgent, within two weeks",
        "pertinent_history": "Two months of burning, boring epigastric pain into the back, worse after meals and lying flat, with nausea, early fullness and pale loose stools; black stools on and off for three weeks; two near-fainting spells. An urgent care visit five weeks ago treated it as indigestion. Weight 56.2 kg, down 5 kg. Pulse 102; epigastric tenderness; slight scleral icterus; no mass or nodes. Results today: hemoglobin 9.1 g/dL, MCV 74 fL, ferritin 6 ng/mL, platelets 388; glucose 132 mg/dL and A1c 6.6%; alkaline phosphatase 236 U/L, total bilirubin 1.6 mg/dL, ALT 48 and AST 41 U/L; lipase 52 U/L; creatinine 0.70 mg/dL; albumin 3.6 g/dL. Started on pantoprazole; intravenous iron arranged. No medicines before today; no known allergies. Never smoker. Her father died suddenly of a cerebral hemorrhage; no known cancer in her family. She is a playwright finishing a new play, wants to be told everything plainly, and wants to keep writing through any treatment",
        "questions": [
          "What is the diagnosis and its stage, and what further tests are needed to decide whether it can be removed?",
          "What treatment do you recommend, in what order (chemotherapy, surgery, or both), and what is its aim?",
          "Which genetic tests should be done, on her blood and on the tumor, and what would the results mean for her and her family?",
          "How should her pain, nutrition, digestion, new diabetes and anemia be managed during treatment, and when should palliative care start?",
          "What is her risk of blood clots, and what should be done about it given the bleeding?",
          "What should she know about fertility and contraception, and what monitoring should primary care share?"
        ]
      },
      "consultant_note": {
        "history": "Ms. Hansberry, 32, is seen at the request of Dr. Marchetti-Fields two weeks after she presented with two months of epigastric and back pain, weight loss, black stools with iron deficiency anemia, and new diabetes. Since then she has had an upper endoscopy, a pancreas-protocol CT, an endoscopic ultrasound with biopsy and a biliary stent, two doses of intravenous iron, and review at our pancreatic tumor board. The pain is 6 out of 10 and breaks her sleep; her stools are pale and float after fatty meals; there has been no black stool since the iron. She works at home as a playwright and is active most of the day (ECOG 1). She is not pregnant and has no children. She asked for the facts in plain words",
        "data_reviewed": "Dr. Marchetti-Fields's intake note and results. Upper endoscopy: an ulcerated, oozing mass on the medial wall of the second part of the duodenum beside the papilla, no peptic ulcer; biopsies: adenocarcinoma infiltrating from the pancreas. Pancreas-protocol CT with CT of the chest: 3.1 cm hypoattenuating mass in the pancreatic head invading the duodenum; common bile duct 13 mm and pancreatic duct 5 mm; contact with about 200 degrees of the superior mesenteric vein with short-segment narrowing that can be reconstructed; no contact with the superior mesenteric artery, celiac axis or common hepatic artery; no liver, peritoneal or lung lesion. EUS-guided biopsy: pancreatic adenocarcinoma, moderately differentiated; extra cores held for molecular profiling. ERCP: fully covered metal stent across a distal bile duct stricture. Today: bilirubin 0.9 mg/dL, alkaline phosphatase 168 U/L, CA 19-9 486 U/mL (after drainage), CEA 3.9 ng/mL, hemoglobin 10.4 g/dL, neutrophils 4.6, platelets 366, creatinine 0.68 mg/dL, albumin 3.5 g/dL, fasting glucose 141 mg/dL, INR 1.0",
        "exam": [
          {
            "system": "General",
            "finding": "Thin, tired, composed; weight 55.4 kg; blood pressure 108/68, pulse 92; ECOG 1"
          },
          {
            "system": "Eyes",
            "finding": "Slight scleral icterus, less than at the first visit"
          },
          {
            "system": "Abdomen",
            "finding": "Epigastric tenderness without guarding; no mass, liver enlargement or ascites"
          },
          {
            "system": "Lymph nodes",
            "finding": "No supraclavicular nodes; no umbilical nodule"
          }
        ],
        "assessment": [
          {
            "problem_id": "PRB-004",
            "display": "Adenocarcinoma of the head of the pancreas, borderline resectable",
            "assessment": "Pancreatic ductal adenocarcinoma of the head of the pancreas invading the duodenum, which explains the bleeding, the anemia, the obstructed bile and pancreatic ducts, the pain and the new diabetes. By NCCN criteria it is borderline resectable, because the tumor contacts more than half the circumference of the superior mesenteric vein, although the vein can be reconstructed and no artery is involved; there is no distant spread on CT. For borderline resectable disease, chemotherapy first is preferred over going straight to surgery: it treats cancer that may already have spread unseen, can shrink the tumor away from the vein, and shows whether the cancer is controlled before a major operation. She is young and fit, with normal kidney function and bilirubin now normal, so modified FOLFIRINOX is the regimen of choice. The aim is cure, and surgery after chemotherapy offers the best chance of it; she was also told honestly that pancreatic cancer often returns even after successful surgery"
          },
          {
            "problem_id": "PRB-005",
            "display": "Diabetes due to the pancreatic cancer",
            "assessment": "New diabetes with weight loss at her age is caused by the cancer (type 3c), not type 2. It may worsen after removal of the head of the pancreas, and insulin is the treatment if glucose-lowering is needed; dexamethasone should be limited"
          },
          {
            "problem_id": "PRB-006",
            "display": "Exocrine pancreatic insufficiency",
            "assessment": "Pale floating stools and weight loss with a blocked pancreatic duct: start enzyme replacement now on clinical grounds, without waiting for a stool test"
          },
          {
            "problem_id": "PRB-007",
            "display": "Cancer-related pain",
            "assessment": "Moderate tumor pain; low-dose opioid with a bowel regimen first, and EUS-guided celiac plexus neurolysis if it becomes severe"
          }
        ],
        "recommendations": [
          "Modified FOLFIRINOX every two weeks for six cycles (about three months) before surgery, through a port: oxaliplatin 85 mg/m2, irinotecan 150 mg/m2, leucovorin 400 mg/m2 and fluorouracil 2400 mg/m2 over 46 hours, with pegfilgrastim on day 3; dose reductions for toxicity rather than delays where possible",
          "Restaging with CA 19-9 every two cycles and pancreas-protocol CT after four and after six cycles; tumor board review after restaging, and pancreaticoduodenectomy with vein resection if there is no progression",
          "Chemotherapy after surgery to complete about six months of treatment in all, the regimen chosen by her tolerance and the pathology",
          "Germline multigene panel after genetic counseling, as for every patient with pancreatic cancer, and tumor molecular profiling on the EUS cores; cascade testing for blood relatives only if a germline variant is found",
          "Hepatitis B, hepatitis C and HIV screening and a pregnancy test before cycle 1; PCV20 and recombinant zoster vaccine now, before chemotherapy; no live vaccines",
          "Antiemetic prevention with fosaprepitant, palonosetron, one day of dexamethasone and olanzapine on days 1 to 4, sparing further dexamethasone because of her diabetes; loperamide teaching for irinotecan diarrhea; neuropathy checks before each oxaliplatin dose",
          "Palliative care from now, alongside cancer treatment; oxycodone 5 mg as needed with senna; pancrelipase about 72,000 lipase units with meals and half that with snacks; dietitian review",
          "Home glucose monitoring, no glucose-lowering drug for now, insulin after surgery if needed; dilated eye examination and urine albumin at diagnosis of diabetes",
          "Khorana score 3: prophylactic apixaban 2.5 mg twice daily once the duodenal bleeding has settled for several weeks; enoxaparin for four weeks after surgery",
          "Fertility counseling before chemotherapy; effective non-estrogen contraception during treatment",
          "Primary care to share the monitoring: blood counts and glucose at visits, mood and distress screening, weight, and help with symptoms between oncology visits"
        ],
        "communication": "Discussed with Dr. Marchetti-Fields the same day and presented at the pancreatic tumor board with surgery, radiology and pathology. The images and biopsy results were explained to Ms. Hansberry in plain words, with the aim of treatment and its uncertainty; she chose to start chemotherapy without delaying for fertility preservation. She decides who else receives this note",
        "follow_up": "Port placement next week; cycle 1 in two weeks; oncology review before each cycle; restaging after cycles 4 and 6; Dr. Marchetti-Fields continues primary care and shares the monitoring"
      },
      "guideline_ids": [
        "GL-NCCN-PANC-2026",
        "GL-ASCO-PANC-2016",
        "GL-ASCO-PANC-2019",
        "GL-ASCO-PANCGERM-2019",
        "GL-ASCO-PALL-2024",
        "GL-ASCO-VTE-2023",
        "GL-ASCO-ANTIEMETIC-2020",
        "GL-ASCO-HBV-2020",
        "GL-ASCO-FERT-2018",
        "GL-ADA-2026"
      ]
    }
  },
  "care_plan": {
    "health_concerns": [
      {
        "id": "HC-001",
        "display": "Burning, boring pain under the breastbone and through to the back for about two months, worse after meals and at night; black stools on and off for three weeks; two near-fainting spells; weight down 5 kg",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic presenting concern anchored to the documented collapse in pain and the account of anemia and bleeding ulcers.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "HC-002",
        "display": "An urgent care clinic put the pain down to indigestion and stress five weeks ago; she does not want it put down to stress again, and wants the cause found and told to her plainly, whatever it is",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic patient-centered concern; it reflects the documented delays in diagnosis and treatment that Black patients with pancreatic cancer face.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "HC-003",
        "display": "She wants to finish her play and to keep writing through whatever treatment she needs, with a clear head",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic concern anchored to her documented work through her illness.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      }
    ],
    "goals": [
      {
        "id": "GOAL-001",
        "display": "Endoscopy and pancreas-protocol CT within one week, tissue diagnosis and biliary drainage within two weeks, and a tumor board plan within three weeks of presentation",
        "status": "completed",
        "target_date": "2026-05-04",
        "outcome": "Endoscopy in two days, CT in three, EUS biopsy and stent in one week, tumor board in nine days, consultation at two weeks",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic diagnostic-pathway goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "GOAL-002",
        "display": "Germline genetic testing with counseling and tumor molecular profiling resulted before surgery",
        "status": "completed",
        "target_date": "2026-06-29",
        "outcome": "Germline panel negative; tumor KRAS G12D, microsatellite stable, no targetable alteration",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic genetics goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "GOAL-003",
        "display": "Six cycles of modified FOLFIRINOX before surgery with no delay of more than one week",
        "status": "completed",
        "target_date": "2026-08-10",
        "outcome": "Six cycles; one dose reduction of irinotecan after diarrhea; CT shows a partial response",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic treatment goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "GOAL-004",
        "display": "Resection with clear margins if restaging shows no progression",
        "status": "completed",
        "target_date": "2026-10-05",
        "outcome": "Pancreaticoduodenectomy with vein resection; margins clear (R0)",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic surgical goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "GOAL-005",
        "display": "Pain 3 out of 10 or less with a clear head for writing",
        "status": "completed",
        "target_date": "2026-06-29",
        "outcome": "Pain 1 to 2 out of 10 on oxycodone 5 mg once or twice a day",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic symptom goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "GOAL-006",
        "display": "Weight kept within 5 percent of the weight at diagnosis through chemotherapy, with enzyme replacement and dietitian support",
        "status": "completed",
        "target_date": "2026-08-10",
        "outcome": "Weight 54.2 kg before surgery, 2 percent below the weight at diagnosis",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic nutrition goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "GOAL-007",
        "display": "PHQ-9 below 10 throughout treatment, with support she chooses and palliative care alongside cancer treatment",
        "status": "completed",
        "target_date": "2026-10-05",
        "outcome": "PHQ-9 between 6 and 8",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic psychosocial goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      }
    ],
    "interventions": [
      {
        "id": "INT-001",
        "display": "Medical oncology consultation within two weeks to review the endoscopy, CT and any biopsy with her and plan treatment if cancer is found",
        "status": "completed",
        "guideline_ids": [
          "GL-NCCN-PANC-2026",
          "GL-ASCO-PANC-2016"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic specialist consultation booked at intake so that a positive result reaches a specialist without delay.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "INT-002",
        "display": "Urgent work-up of epigastric pain with weight loss, anemia and new diabetes: upper endoscopy within days, pancreas-protocol CT of the abdomen with CT of the chest, blood count, ferritin, liver tests, lipase and A1c; pantoprazole until the endoscopy; return at once for fresh black stools, fainting or yellow eyes",
        "status": "completed",
        "guideline_ids": [
          "GL-NCCN-PANC-2026",
          "GL-NOEL-2019"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic diagnostic pathway; it guards against the delays that contribute to worse outcomes for Black patients with pancreatic cancer.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "INT-003",
        "display": "Intravenous iron for iron deficiency anemia from blood loss, with a blood count at each visit",
        "status": "completed",
        "guideline_ids": [
          "GL-NCCN-PANC-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic anemia plan.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      },
      {
        "id": "INT-004",
        "display": "Tissue and staging: EUS-guided biopsy with extra cores for molecular profiling, biliary drainage with a metal stent, CA 19-9 after the bilirubin is normal, and review at the pancreatic tumor board",
        "status": "completed",
        "guideline_ids": [
          "GL-NCCN-PANC-2026",
          "GL-ASCO-PANC-2016"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic staging plan decided when the endoscopy and CT showed a mass.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        },
        "recorded_date": "2026-05-04"
      },
      {
        "id": "INT-005",
        "display": "Germline genetic testing with counseling for every patient with pancreatic cancer, and tumor molecular profiling (including KRAS, BRCA1, BRCA2, PALB2, mismatch repair, NTRK and NRG1); cascade testing offered to blood relatives only if a germline variant is found",
        "status": "completed",
        "guideline_ids": [
          "GL-NCCN-PANC-2026",
          "GL-ASCO-PANCGERM-2019",
          "GL-ASCO-MPC-2020"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic genetics plan decided at the diagnosis visit.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        },
        "recorded_date": "2026-05-04"
      },
      {
        "id": "INT-006",
        "display": "Modified FOLFIRINOX (oxaliplatin 85 mg/m2, irinotecan 150 mg/m2, leucovorin 400 mg/m2, fluorouracil 2400 mg/m2 over 46 hours) every two weeks for six cycles (three months) before surgery through a port, with pegfilgrastim, olanzapine-based antiemetic prevention that spares dexamethasone because of her diabetes, loperamide for late diarrhea, and neuropathy checks; CA 19-9 every two cycles and restaging CT after four and six cycles; hepatitis B, hepatitis C and HIV screening and a pregnancy test first",
        "status": "completed",
        "guideline_ids": [
          "GL-NCCN-PANC-2026",
          "GL-ASCO-PANC-2016",
          "GL-ASCO-PANC-2019",
          "GL-ASCO-ANTIEMETIC-2020",
          "GL-ASCO-CIPN-2020",
          "GL-ASCO-HBV-2020"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic treatment chosen at the tumor board for borderline resectable disease in a fit young patient.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        },
        "recorded_date": "2026-05-04"
      },
      {
        "id": "INT-007",
        "display": "Palliative care from the day of diagnosis, alongside cancer treatment: symptom control, a serious illness conversation, and planning that keeps her writing at the center; oxycodone 5 mg as needed with a bowel regimen, and EUS-guided celiac plexus neurolysis if pain becomes severe",
        "status": "completed",
        "guideline_ids": [
          "GL-ASCO-PALL-2024",
          "GL-NCCN-PANC-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic palliative care plan decided at diagnosis.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        },
        "recorded_date": "2026-05-04"
      },
      {
        "id": "INT-008",
        "display": "Nutrition: dietitian review at each phase, pancrelipase with every meal and snack, small frequent meals, weight at every visit",
        "status": "completed",
        "guideline_ids": [
          "GL-NCCN-PANC-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic nutrition plan decided at diagnosis.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        },
        "recorded_date": "2026-05-04"
      },
      {
        "id": "INT-009",
        "display": "Diabetes due to pancreatic disease: home glucose checks, A1c every three months, glucose checks before each cycle; insulin rather than oral agents if treatment is needed after surgery; dilated eye examination and urine albumin-to-creatinine ratio at diagnosis",
        "status": "completed",
        "guideline_ids": [
          "GL-ADA-2026",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic diabetes plan decided at diagnosis.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        },
        "recorded_date": "2026-05-04"
      },
      {
        "id": "INT-010",
        "display": "Venous thromboembolism: Khorana score recorded (3: pancreatic primary and hemoglobin below 10 g/dL); prophylactic apixaban offered once the duodenal bleeding has settled; enoxaparin for four weeks after surgery",
        "status": "completed",
        "guideline_ids": [
          "GL-ASCO-VTE-2023",
          "GL-AVERT-2019"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic thromboprophylaxis plan decided at diagnosis.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        },
        "recorded_date": "2026-05-04"
      },
      {
        "id": "INT-011",
        "display": "Fertility and contraception: oncofertility counseling before chemotherapy, a pregnancy test before treatment, and effective non-estrogen contraception if she becomes sexually active during treatment",
        "status": "completed",
        "guideline_ids": [
          "GL-ASCO-FERT-2018"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic reproductive plan decided at diagnosis.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        },
        "recorded_date": "2026-05-04"
      },
      {
        "id": "INT-012",
        "display": "Pylorus-preserving pancreaticoduodenectomy with resection of the involved segment of the superior mesenteric vein after restaging shows no progression",
        "status": "completed",
        "guideline_ids": [
          "GL-NCCN-PANC-2026",
          "GL-ASCO-PANC-2016"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic surgical decision made after restaging.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        },
        "recorded_date": "2026-08-10"
      },
      {
        "id": "INT-013",
        "display": "Chemotherapy after surgery to complete about six months of treatment: six cycles of fluorouracil, leucovorin and irinotecan every two weeks, without oxaliplatin because of neuropathy; insulin glargine adjusted to home glucose readings; apixaban prophylaxis resumed during chemotherapy; surveillance afterwards with history, examination, CA 19-9 and CT every three to six months for two years",
        "status": "completed",
        "guideline_ids": [
          "GL-NCCN-PANC-2026",
          "GL-ASCO-PANC-2016",
          "GL-ASCO-PANC-2019",
          "GL-ASCO-VTE-2023"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic plan after surgery decided at the post-operative visit.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        },
        "recorded_date": "2026-10-05"
      },
      {
        "id": "INT-014",
        "display": "Distress and depression screening at each visit, plain explanations with written information, and support she chooses; she decides who is told and who receives each note",
        "status": "completed",
        "guideline_ids": [
          "GL-USPSTF-DEP-2023",
          "GL-ASCO-PALL-2024"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic psychosocial plan.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:30:00-05:00"
        }
      }
    ],
    "guidelines": [
      {
        "guideline_id": "GL-NCCN-PANC-2026",
        "title": "NCCN Clinical Practice Guidelines in Oncology: Pancreatic Adenocarcinoma",
        "publisher": "National Comprehensive Cancer Network",
        "url": "https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1455",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-ASCO-PANC-2016",
        "title": "Khorana AA, et al. Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol 2016;34(21):2541-2556 (PMID 27247221)",
        "publisher": "American Society of Clinical Oncology",
        "url": "https://pubmed.ncbi.nlm.nih.gov/27247221/",
        "version_or_year": "2016"
      },
      {
        "guideline_id": "GL-ASCO-PANC-2019",
        "title": "Khorana AA, et al. Potentially Curable Pancreatic Adenocarcinoma: ASCO Clinical Practice Guideline Update. J Clin Oncol 2019;37(23):2082-2088 (PMID 31180816)",
        "publisher": "American Society of Clinical Oncology",
        "url": "https://pubmed.ncbi.nlm.nih.gov/31180816/",
        "version_or_year": "2019"
      },
      {
        "guideline_id": "GL-ASCO-MPC-2020",
        "title": "Sohal DPS, et al. Metastatic Pancreatic Cancer: ASCO Guideline Update. J Clin Oncol 2020;38(27):3217-3230 (PMID 32755482)",
        "publisher": "American Society of Clinical Oncology",
        "url": "https://pubmed.ncbi.nlm.nih.gov/32755482/",
        "version_or_year": "2020"
      },
      {
        "guideline_id": "GL-ASCO-PANCGERM-2019",
        "title": "Stoffel EM, et al. Evaluating Susceptibility to Pancreatic Cancer: ASCO Provisional Clinical Opinion. J Clin Oncol 2019;37(2):153-164 (PMID 30457921)",
        "publisher": "American Society of Clinical Oncology",
        "url": "https://pubmed.ncbi.nlm.nih.gov/30457921/",
        "version_or_year": "2019"
      },
      {
        "guideline_id": "GL-ASCO-PALL-2024",
        "title": "Sanders JJ, et al. Palliative Care for Patients With Cancer: ASCO Guideline Update. J Clin Oncol 2024;42(19):2336-2357 (PMID 38748941)",
        "publisher": "American Society of Clinical Oncology",
        "url": "https://pubmed.ncbi.nlm.nih.gov/38748941/",
        "version_or_year": "2024"
      },
      {
        "guideline_id": "GL-ASCO-VTE-2023",
        "title": "Key NS, et al. Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Guideline Update. J Clin Oncol 2023;41(16):3063-3071 (PMID 37075273)",
        "publisher": "American Society of Clinical Oncology",
        "url": "https://pubmed.ncbi.nlm.nih.gov/37075273/",
        "version_or_year": "2023"
      },
      {
        "guideline_id": "GL-AVERT-2019",
        "title": "Carrier M, et al. Apixaban to Prevent Venous Thromboembolism in Patients with Cancer (AVERT). N Engl J Med 2019;380(8):711-719 (PMID 30511879)",
        "publisher": "New England Journal of Medicine",
        "url": "https://pubmed.ncbi.nlm.nih.gov/30511879/",
        "version_or_year": "2019"
      },
      {
        "guideline_id": "GL-ASCO-ANTIEMETIC-2020",
        "title": "Hesketh PJ, et al. Antiemetics: ASCO Guideline Update. J Clin Oncol 2020;38(24):2782-2797 (PMID 32658626)",
        "publisher": "American Society of Clinical Oncology",
        "url": "https://pubmed.ncbi.nlm.nih.gov/32658626/",
        "version_or_year": "2020"
      },
      {
        "guideline_id": "GL-ASCO-CIPN-2020",
        "title": "Loprinzi CL, et al. Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update. J Clin Oncol 2020;38(28):3325-3348 (PMID 32663120)",
        "publisher": "American Society of Clinical Oncology",
        "url": "https://pubmed.ncbi.nlm.nih.gov/32663120/",
        "version_or_year": "2020"
      },
      {
        "guideline_id": "GL-ASCO-HBV-2020",
        "title": "Hwang JP, et al. Hepatitis B Virus Screening and Management for Patients With Cancer Prior to Therapy: ASCO Provisional Clinical Opinion Update. J Clin Oncol 2020;38(31):3698-3715 (PMID 32716741)",
        "publisher": "American Society of Clinical Oncology",
        "url": "https://pubmed.ncbi.nlm.nih.gov/32716741/",
        "version_or_year": "2020"
      },
      {
        "guideline_id": "GL-ASCO-FERT-2018",
        "title": "Oktay K, et al. Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update. J Clin Oncol 2018;36(19):1994-2001 (PMID 29620997)",
        "publisher": "American Society of Clinical Oncology",
        "url": "https://pubmed.ncbi.nlm.nih.gov/29620997/",
        "version_or_year": "2018"
      },
      {
        "guideline_id": "GL-ADA-2026",
        "title": "American Diabetes Association Professional Practice Committee. Standards of Care in Diabetes-2026 (classification of diabetes, including diabetes of the exocrine pancreas)",
        "publisher": "American Diabetes Association",
        "url": "https://diabetesjournals.org/care/issue/49/Supplement_1",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-NOEL-2019",
        "title": "Noel M, Fiscella K. Disparities in Pancreatic Cancer Treatment and Outcomes. Health Equity 2019;3(1):532-540 (PMID 31663065)",
        "publisher": "Health Equity (Mary Ann Liebert)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/31663065/",
        "version_or_year": "2019"
      },
      {
        "guideline_id": "GL-DHALI-2026",
        "title": "Dhali A, et al. Racial Disparities in Pancreatic Cancer: A Comprehensive Population-Based Analysis of Survival, Surgical Access, and Prognostic Factors. Am J Clin Oncol 2026 (PMID 41996299)",
        "publisher": "American Journal of Clinical Oncology",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41996299/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-CMID-2026",
        "title": "CMID: Clinical Monitoring Intelligence Database, diabetes mellitus (type 2) and anemia monographs",
        "publisher": "Aether Forge",
        "url": "https://patrickrutledge.github.io/topthirty/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-DEP-2023",
        "title": "Depression and Suicide Risk in Adults: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-depression-suicide-risk-adults",
        "version_or_year": "2023"
      },
      {
        "guideline_id": "GL-ASCO-DIARRHEA-2004",
        "title": "Benson AB 3rd, et al. Recommended guidelines for the treatment of cancer treatment-induced diarrhea. J Clin Oncol 2004;22(14):2918-2926 (PMID 15254061)",
        "publisher": "Journal of Clinical Oncology",
        "url": "https://pubmed.ncbi.nlm.nih.gov/15254061/",
        "version_or_year": "2004"
      },
      {
        "guideline_id": "GL-PREV-2026",
        "title": "Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements",
        "publisher": "Aether Forge",
        "url": "https://patrickrutledge.github.io/preventative_services/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-AB",
        "title": "USPSTF A and B Recommendations",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-a-and-b-recommendations",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-CERV-2018",
        "title": "Cervical Cancer: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/cervical-cancer-screening",
        "version_or_year": "2018"
      },
      {
        "guideline_id": "GL-USPSTF-IPV-2018",
        "title": "Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/intimate-partner-violence-and-abuse-of-elderly-and-vulnerable-adults-screening",
        "version_or_year": "2018"
      },
      {
        "guideline_id": "GL-USPSTF-ALC-2018",
        "title": "Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/unhealthy-alcohol-use-in-adolescents-and-adults-screening-and-behavioral-counseling-interventions",
        "version_or_year": "2018"
      },
      {
        "guideline_id": "GL-CDC-IMZ-2026",
        "title": "Adult Immunization Schedule by Medical Condition and Other Indication",
        "publisher": "Centers for Disease Control and Prevention",
        "url": "https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-medical-condition.html",
        "version_or_year": "2026"
      }
    ]
  },
  "review": {
    "schema_validation": {
      "status": "not_started",
      "notes": "Run scripts/build.ps1 -Conformance."
    },
    "clinical_review": {
      "status": "not_started",
      "notes": "Awaiting clinician review; check the borderline resectable staging, the choice and dosing of modified FOLFIRINOX with a dexamethasone-sparing antiemetic plan, the reading of CA 19-9 after biliary drainage, the timing of apixaban after a bleeding duodenal tumor, insulin for diabetes after pancreaticoduodenectomy, and the chemotherapy after surgery without oxaliplatin."
    },
    "provenance_review": {
      "status": "not_started",
      "notes": "She died in 1965; the recent-death rule does not apply. Claims rest on the PBS American Masters timeline, two reference encyclopedias, Biography.com and Wikipedia. The primary site of her cancer is recorded as R because the sources disagree; everything clinical is synthetic."
    },
    "safe_messaging_review": {
      "status": "not_started",
      "notes": "No mental health or substance claim is made; mood screens are synthetic and below the threshold for a safety assessment. Her death is recorded once, without detail. No relative, friend or historical physician is given a role in the modern episode, and her private relationships are not used beyond the documented marriage."
    }
  }
}
